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SUMMARY 
The exon junction complex (EJC) deposited upstream of mRNA exon junctions shapes 
structure, composition and fate of spliced mRNA ribonucleoprotein particles (mRNPs). 
To achieve this, the EJC core nucleates assembly of a dynamic shell of peripheral 
proteins that function in diverse post-transcriptional processes. To illuminate 
consequences of EJC composition change, we purified EJCs from human cells via 
peripheral proteins RNPS1 and CASC3. We show that EJC originates as an SR-rich 
mega-dalton sized RNP that contains RNPS1 but lacks CASC3. After mRNP export to 
the cytoplasm and before translation, the EJC undergoes a remarkable compositional 
and structural remodeling into an SR-devoid monomeric complex that contains CASC3. 
Surprisingly, RNPS1 is important for nonsense-mediated mRNA decay (NMD) in 
general whereas CASC3 is needed for NMD of only select mRNAs. The promotion of 
switch to CASC3-EJC slows down NMD. Overall, the EJC compositional switch 
dramatically alters mRNP structure and specifies two distinct phases of EJC-dependent 
NMD. 	  
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INTRODUCTION 
From the time of their birth during transcription until their eventual demise following 
translation, messenger RNAs (mRNA) exist decorated with proteins as mRNA-protein 
particles, or mRNPs (Gehring et al., 2017; Singh et al., 2015). The vast protein 
complement of mRNPs has been recently illuminated (Baltz et al., 2012; Castello et al., 
2012; Hentze et al., 2018), and is believed to change as mRNPs progress through 
various life stages. However, the understanding of mechanisms and consequences of 
mRNP composition change remains confined to only a handful of its components. For 
example, mRNA export adapters are removed upon mRNP export to provide 
directionality to mRNP metabolic pathways, and the nuclear cap and poly(A)-tail binding 
proteins are exchanged for their cytoplasmic counterparts after mRNP export to 
promote translation (Singh et al., 2015, and references therein). When, where and how 
the multitude of mRNP components change during it’s lifetime, and how such changes 
impact mRNP function remain largely unknown. 
A key component of all spliced mRNPs is the exon junction complex (EJC), 
which assembles during pre-mRNA splicing 24 nucleotides (nt) upstream of exon-exon 
junctions (Boehm and Gehring, 2016; Le Hir et al., 2016; Woodward et al., 2017). Once 
deposited, the EJC enhances gene expression at several post-transcriptional steps 
including pre-mRNA splicing, mRNA export, mRNA transport and localization, and 
translation. If an EJC remains bound to an mRNA downstream of a ribosome 
terminating translation, it stimulates rapid degradation of the mRNA via nonsense-
mediated mRNA decay (NMD). The stable EJC core forms when RNA bound EIF4A3 is 
locked in place by RBM8A (also known as Y14) and MAGOH. It has been proposed that 
this trimeric complex is joined by a fourth protein CASC3 (also known as MLN51 or 
Barenstz) to form a stable tetrameric core (Boehm and Gehring, 2016; Hauer et al., 
2016; Le Hir et al., 2016; Tange et al., 2005). However, more recent evidence suggests 
that CASC3 may not be present in all EJCs and may not be necessary for all EJC 
functions (Mao et al., 2017; Singh et al., 2012). Nonetheless, the stable EJC core is 
bound by a dynamic shell of peripheral EJC proteins such as pre-mRNA splicing factors 
(e.g. SRm160, RNPS1), mRNA export proteins (e.g. the TREX complex), translation 
factors (e.g. SKAR) and NMD factors (e.g. UPF3B) (Boehm and Gehring, 2016; Le Hir 
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et al., 2016; Woodward et al., 2017). Some peripheral EJC proteins share similar 
functions and yet may act on different mRNAs; e.g. RNPS1 and CASC3 can both 
enhance NMD but may have distinct mRNA targets (Gehring et al., 2005). Thus, the 
peripheral EJC shell may vary between mRNPs leading to compositionally distinct 
mRNPs, an idea that has largely remained untested. 
We previously showed that within spliced mRNPs EJCs interact with one another 
as well as with several SR and SR-like proteins to assemble into mega-dalton sized 
RNPs (Singh et al., 2012). These stable mega RNPs ensheath RNA well beyond the 
canonical EJC deposition site leading to RNA footprints ranging from 150-200 nt in 
length, suggesting that the RNA polymer within these complexes is packaged resulting 
in overall compact mRNP structure. Such a compact structure may facilitate mRNP 
navigation of the intranuclear environment, export through the nuclear pore and 
transport within the cytoplasm to arrive at its site of translation. Eventually, the mRNA 
within mRNPs must be unpacked to allow access to the translation machinery. How 
long do mRNPs exist in their compact states, and when, where and how are they 
unfurled remains yet to be understood.  
Our previous observation that in human embryonic kidney (HEK293) cells 
CASC3 and many peripheral EJC factors are substoichiometric to the EJC core (Singh 
et al., 2012) spurred us to investigate variability in EJC composition. Here we use EJC 
purification via substoichiometric factors to reveal that EJCs first assemble into SR-rich 
mega-dalton sized RNPs, and then undergo a compositional switch into SR-devoid 
monomeric CASC3-containing EJC. The translationally repressed mRNPs, particularly 
those encoding ribosomal proteins, accumulate with the CASC3-bound form of the EJC. 
Although both the EJC forms remain active in NMD, RNPS1, a component of the SR-
rich EJCs, is crucial for all tested NMD events whereas CASC3, a constituent of SR-
devoid EJC, is dispensable for NMD of many transcripts. Our findings reveal a new step 
in the mRNP life cycle wherein EJCs, and by extension mRNPs, undergo a remarkable 
compositional switch that alters the mRNP structure and specifies two distinct phases of 
EJC dependent NMD.	  
	6	
RESULTS  
RNPS1 and CASC3 associate with the EJC core in a mutually exclusive manner 
We reasoned that substoichiometric EJC proteins may not interact with all EJC cores, 
and therefore, some of them may not interact with each other leading to variable EJC 
composition. To test such a prediction, we carried out immunoprecipitations (IP) of 
either endogenous core factor EIF4A3 or the substoichiometric EJC proteins RNPS1 
and CASC3 from RNase A-treated HEK293 total cell extracts. As expected, EIF4A3 IP 
enriches EJC core as well as all peripheral proteins tested (Figure 1A, lane 3). In 
contrast, the IPs of substoichiometric factors enriched only distinct sets of proteins. 
CASC3 immunopurified the EJC core proteins (EIF4A3, RBM8A and MAGOH) but not 
the peripheral proteins ACIN1 and SAP18 (Figure 1A, lane 4; RNPS1 could not be 
blotted for as it co-migrates with IgG heavy chain). Conversely, following RNPS1 IP, the 
EJC core proteins as well as its known binding partner SAP18 (Murachelli et al., 2012; 
Tange et al., 2005) were enriched but CASC3 was undetected in these IPs. We saw an 
identical lack of co-IP between RNPS1 and CASC3 from cells that were crosslinked with 
formaldehyde prior to lysis (data not shown; also see below), suggesting that the lack of 
interaction between these substoichiometric factors does not result from their 
dissociation following cell lysis. We also carried out similar IPs from RNase-treated total 
extracts from mouse brain cortical slices, mouse embryonal carcinoma (P19) cells, and 
HeLa cells. Again, both RNPS1 and CASC3 efficiently co-IPed with EIF4A3 from these 
lysates but no co-IP was detected between RNPS1 and CASC3 (compare lanes 4 and 5 
with lane 3 in Figures 1B, S1A and S1B). Therefore, we conclude that in mammalian 
cells RNPS1 and CASC3 exist in complex with the EJC core in a mutually exclusive 
manner, and term these compositionally distinct EJCs as alternate EJCs.  
 
Proteomic Analysis of Alternate EJCs 
To gain insights into alternate compositions of the EJC, we further characterized 
RNPS1 and CASC3-containing complexes using a bottom-up proteomics approach. We 
generated HEK293 cell lines stably expressing FLAG-tagged RNPS1 and CASC3 from 
a tetracycline inducible promoter where the proteins are induced at near endogenous 
levels (Figure S1C). FLAG IPs from RNase-treated total extracts of FLAG-RNPS1 and 
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FLAG-CASC3 expressing cells confirmed that the tagged proteins also exist in mutually 
exclusive EJCs (Figure S1D). Importantly, proteomic analysis of FLAG-affinity purified 
alternate EJCs show almost complete lack of spectra corresponding to RNPS1 and 
CASC3 in the immunoprecipitates of the other alternate EJC factor (Figures 1C and 
S1E). In comparison, a FLAG-MAGOH IP enriches both CASC3 and RNPS1 as 
expected (Figures 1C, S1D and S1E). 
We next compared the full complement of proteins associated with FLAG-
RNPS1, FLAG-CASC3 and FLAG-MAGOH focusing on proteins >2-fold enriched in any 
one of the three EJC IPs as compared to the FLAG-only negative control (Table S1; see 
Experimental Procedures). Of the 59 proteins enriched in the two FLAG-RNPS1 
biological replicates (Figure S2A), 38 are common with the 45 proteins identified in the 
two FLAG-MAGOH replicates (Figures S2A and S2B). Such a high degree of overlap 
suggests that RNPS1 containing complexes are compositionally similar to those purified 
via the EJC core. In comparison, among the two FLAG-CASC3 replicates the only 
common proteins are EIF4A3 and MAGOH (Figure S2A), which are also shared with 
FLAG-MAGOH (Figure S2C). Known EJC interactors such as UPF3B and PYM1 are 
identified in only one of the two FLAG-CASC3 replicates indicating less stable CASC3 
association with these EJC factors.  
A direct comparison of FLAG-RNPS1 and FLAG-CASC3 proteomes highlights 
their stark differences beyond the common EJC core (Figures 2A and 2B). Several SR 
and SR-like proteins are enriched in the RNPS1 and MAGOH proteomes but are 
completely absent from the CASC3 samples. Among the SR protein family, SRSF1, 6, 7 
and 10 are reproducibly enriched in all RNPS1 and MAGOH samples, while all other 
canonical SR proteins, with the exception of non-shuttling SRSF2, are detected in at 
least one of the two replicates (Figure 2A, 2B, 2C and Table S1). Several SR-like 
proteins such as ACIN1, PNN, SRRM1 and SRRM2 are also highly enriched in MAGOH 
and RNPS1 IPs but are absent in CASC3 IPs (Figure 2 and Table S1). A weak but 
erratic signal for SRSF1 and SAP18 is seen in FLAG-CASC3 IPs (e.g. spectra for two 
SRSF1-derived peptides are observed in one of the FLAG-CASC3 samples; Figure 2B). 
However, their enrichment in CASC3-EJC is much weaker as compared to MAGOH or 
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RNPS1 samples. Overall, these findings suggest an extensive interaction network 
between SR and SR-like proteins and the RNPS1-EJC but not the CASC3-EJC.   
The proteomes of the three EJC factors can be readily classified based on 
protein functions in RNA biogenesis, their assembly/function within RNPs, or their 
protein sequence composition (Figure 2B). Many RNA biogenesis factors are 
specifically associated with RNPS1 (and MAGOH) but not with CASC3. These include 
transcription machinery components (e.g. RPB1, RPB2), transcriptional regulators (e.g. 
CD11A, CDK12) as well as RNA processing factors (e.g. NCBP1, FIP1). Consistent 
with EJC core assembly during pre-mRNA splicing, MAGOH and RNPS1 interactors 
also include U2, U4 and U6 snRNP components and nineteen complex subunits. None 
of the splicing components are seen to interact with CASC3. Considering that SR 
proteins also assemble onto nascent RNAs co-incident with transcription and splicing 
(Zhong et al., 2009), the EJC-RNPS1-SR interaction network likely originates during co-
transcriptional mRNP biogenesis. In contrast, CASC3 most likely engages with the EJC 
only post-splicing, as previously suggested (Gehring et al., 2009a).  
 
Alternate EJCs differ in their higher order structure 
The enrichment of SR and SR-like proteins exclusively with RNPS1 suggested that 
RNPS1 EJCs are likely to resemble the previously described higher order EJCs (Singh 
et al., 2012). Indeed, glycerol gradient fractionation of RNase-treated complexes 
immunopurified via FLAG-RNPS1 shows that, like EJCs purified via FLAG-MAGOH, 
FLAG-RNPS1 EJCs contain both lower and higher molecular weight complexes (Figure 
2D). On the other hand CASC3 is mainly detected in lower molecular weight complexes 
purified via FLAG-MAGOH (Figure 2D, compare CASC3 signal in fractions 2-10 and 22-
24). Furthermore, complexes purified via FLAG-CASC3 are exclusively comprised of 
lower molecular weight complexes, likely to be EJC monomers (Figure 2D). These 
findings are consistent with the proteomic results and suggest that compositional 
distinctions between the two alternate EJCs give rise to two structurally distinct 
complexes.  
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RNPS1 and CASC3 bind RNA via the EJC core with key distinctions  
We next identified the RNA binding sites for the two alternate EJC factors using 
RNA:protein immunoprecipitation in tandem (RIPiT) combined with high-throughput 
sequencing, or RIPiT-Seq (Singh et al., 2012, 2014). RIPiT-Seq entails tandem 
purification of two subunits of an RNP, and is well-suited to study EJC composition via 
sequential IP of its constant (e.g. EIF4A3, MAGOH) and variable (e.g. RNPS1, CASC3) 
components (Figure 3A). We carried out RIPiTs from HEK293 cells by either pulling first 
on FLAG-tagged alternate EJC factor followed by IP of an endogenous core factor, or 
vice versa. As a control, we also performed FLAG-MAGOH:EIF4A3 RIPiT-Seq. All in 
vivo EJC binding studies thus far have employed a short incubation with translation 
elongation inhibitor cycloheximide prior to cell lysis to limit EJC disassembly by 
translating ribosomes (Hauer et al., 2016; Saulière et al., 2012; Singh et al., 2012). 
However, to capture unperturbed, steady-state populations of RNPS1 and CASC3 
bound EJCs (as in Figures 1 and 2), we performed RIPiT-Seq without translation 
inhibition.  
As expected, RIPiTs for each of the two alternate EJCs specifically purified the 
targeted complex along with the EJC core factors and yielded abundant RNA footprints 
(Figure S3A). Strand-specific RIPiT-Seq libraries from ~35-60 nucleotide footprints 
yielded ~5.7 to 47 million reads, of which >80% mapped uniquely to the human genome 
(hg38; Table S2). Genic read counts are highly correlated between RIPiTs where the 
order of IP of EJC core and alternate factors was reversed (Figures S3B and S3C). We 
found that RNPS1-EJC core interaction is susceptible to NaCl concentrations greater 
than 250 mM whereas CASC3-EJC core interaction persists up to 600 mM NaCl (data 
not shown). Therefore, to preserve labile interactions we performed alternate EJC 
RIPiTs from cells cross-linked with formaldehyde before cell lysis (Figure S3D). We 
observed a strong correlation for genic read counts between crosslinked and 
uncrosslinked samples (Figures S3E and S3F). The analysis presented below is from 
two well-correlated biological replicates of formaldehyde crosslinked RIPiT-Seq 
datasets of RNPS1- and CASC3-EJC (Figures S3G and S3H). 
Consistent with EJC deposition on spliced RNAs, alternate EJC footprints are 
enriched in exonic sequences from multi-exon genes (Figure S3I). Along individual 
	10	
exons, footprints of both alternate EJCs mainly occur close to exon 3’ ends (Figure 3B). 
Indeed, a meta-exon analysis shows that the alternate EJC factors bind mainly to the 
canonical EJC binding site 24 nt upstream of exon junctions (Figure 3C) (Hauer et al., 
2016; Saulière et al., 2012; Singh et al., 2012). Notably, the alternate EJC footprint 
enrichment at the canonical EJC site is irrespective of whether the alternate EJC factors 
are IPed first or second during the RIPiT procedure (Figure S3J). Thus, both RNPS1 
and CASC3 mainly bind to RNA via EJCs at the canonical site. The location of the 5’- 
and 3’-ends of the alternate EJC footprint reads shows that both alternate EJCs have a 
similar footprint on RNA as each blocks positions -26 to -19 nt from RNase I cleavage 
(Figure 3D). Our findings are consistent with previous work that showed that CASC3 
mainly binds to the canonical EJC site (Hauer et al., 2016). However, in contrast to this 
study, RNPS1 binding to canonical EJC sites is readily apparent (Figures 3B, 3C and 
3D), which could reflect differences in the UV-crosslinking dependent CLIP-Seq 
approach used by Hauer et al. and the photo-crosslinking independent RIPiT-Seq. 
Altogether, our results suggest that both RNPS1 and CASC3 exist in complex with EJC 
at its canonical site. 
While read densities for both alternate EJC factors are highest at the canonical 
EJC site, 47-62% of reads map outside of the canonical EJC site similar to previous 
estimates (Saulière et al., 2012; Singh et al., 2012). Non-canonical footprints are 
somewhat more prevalent in RNPS1-EJC as compared to CASC3-EJC (Figure S3K). 
As RNPS1-EJC is intimately associated with SR and SR-like proteins (Figure 2A and 
B), a k-mer enrichment analysis revealed a modest but significant enrichment of GA-rich 
6-mers in RNPS1 over CASC3 footprints (Figures 3E). Such purine-rich sequences 
occur in binding sites of several SR proteins (SRSF1, SRSF4, Tra2a and b) (Änkö et al., 
2012; Pandit et al., 2013; Tacke et al., 1998). There is also a small but significant 
enrichment of sequence motifs recognized by SRSF1 and SRSF9 in RNPS1 footprints 
as compared to CASC3 footprints or RNA-Seq reads (Figures 3F, 3G, S3L and S3M). 
We conclude that within spliced RNPs, RNPS1-containing EJC is engaged with SR and 
SR-like proteins, and other RNA binding proteins, which leads to co-enrichment of RNA 
binding sites of these proteins during RIPiT via RNPS1. Intriguingly, CG-rich 3-mers are 
the highest enriched k-mers in footprints of both alternate EJCs as compared to RNA-
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Seq (data not shown). The CG-rich 6-mers are also somewhat more enriched in 
RNPS1-EJC (Figure 3E). A CG-rich sequence was reported as an in vitro RBM8A 
binding motif indicating a yet to be determined relationship between the EJC core and 
CG-rich sequences (Ray et al., 2013).  
 
RNPS1 and CASC3 RNA occupancy changes with mRNP subcellular location  
Surprisingly, despite the mutually exclusive association of RNPS1 and CASC3 with the 
EJC core (Figures 1 and 2), the two proteins are often detected on the same sites on 
RNA leading to their similar apparent occupancy on individual exons as well as entire 
transcripts (Figures 3B, S4A and S4B). These results suggest that the two alternate 
EJC factors bind to two distinct pools of the same RNAs. To further reveal RNA binding 
patterns of the alternate EJC factors, we first identified exons differentially enriched in 
one or the other factor. Remarkably, if two or more exons of the same gene are 
differentially enriched in RNPS1 or CASC3 footprints, these exons are almost always 
enriched in the same alternate EJC factor (Figure 4A, p < 0.00001). This extremely tight 
linkage between EJC compositions of different exons of the same gene suggests that 
RNPS1 and CASC3 binding to EJC is determined at the level of the entire transcript and 
not of the individual exon. At any given time a transcript with multiple EJCs is likely to be 
homogeneously associated with either one or the other alternate factor. In support of 
this scenario, very weak RNA-dependent interaction is detected between the two 
alternate EJC factors (Figure S4C). 
 At steady state, RNPS1 is mainly localized to the nucleus whereas CASC3 is 
predominantly cytoplasmic although both proteins shuttle between the two 
compartments (Daguenet et al., 2012; Degot et al., 2002; Lykke-Andersen et al., 2001). 
We reasoned that different concentration of alternate EJC factors in the two subcellular 
compartments may mirror their EJC association and RNA occupancy. To test this 
possibility, we identified subsets of transcripts that are preferentially enriched in RNPS1- 
(242 transcripts) or CASC3-EJC (625 transcripts; Figure 4B), and compared their 
nuclear:cytoplasmic ratios based on estimates of subcellular RNA distribution in 
HEK293 cells (Neve et al., 2016). Indeed, the transcripts enriched in CASC3-EJC 
strongly localize to the cytoplasm (median % localized in cytoplasm = 76), whereas 
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those preferentially bound to RNPS1 show more even distribution with a slight bias for 
nuclear localization (median % localized in cytoplasm = 48; Figures 4C and S4D). Thus, 
subcellular localization of spliced RNAs and EJC factors are important determinants of 
EJC composition.  
We surmised that kinetics of mRNA maturation and in turn nuclear export will 
directly impact EJC composition. To test this idea, we compared alternate EJC 
occupancy of a group of genes whose nuclear poly(A)-tailed transcripts contain introns 
that undergo splicing much more slowly as compared to other introns in the same 
transcript (Boutz et al., 2015). Transcripts containing these detained introns (DI) are 
restricted to the nucleus in a mostly pre-processed state until DIs are spliced, and are 
therefore expected to have slower mRNA export rates. Of the genes that Boutz et al. 
found to contain DI in four human cell lines, 542 also contained DIs in HEK293 cells 
whereas a set of 389 transcripts do not contain DI in any human cell lines including 
HEK293 cells (data not shown). We find that DI-containing transcripts are significantly 
more enriched in RNPS1-EJC (p=8.3x10-13, Figures 4D and 4E) while DI lacking 
transcripts show an enrichment in CASC3-EJC (p=1.8x10-7). These results support our 
conclusion that EJC (and mRNP) compositional switch mainly occurs as they mature 
and enter the cytoplasm, and that the rate of mRNA progression to the cytoplasm alters 
the switch.  
 Despite a strong CASC3 enrichment on cytoplasmic RNAs, a quarter of all 
preferentially CASC3-bound RNAs are more nuclear (Figure 4C).  Consistent with 
CASC3 shuttling into the nucleus (Daguenet et al., 2012; Degot et al., 2002), its 
footprints are abundantly detected on XIST RNA and several other spliced non-coding 
RNAs restricted or enriched in the nucleus (Figures 4F and S4D). Further, in HEK293 
nuclear as well as cytoplasmic extracts both CASC3 and RNPS1 are found to assemble 
into EJCs (Figures S4E and S4F). These data suggest that while the bulk of RNPs may 
undergo the switch in EJC composition in the cytoplasm, some RNPs can undergo this 
change in the nucleus itself, possibly as a function of RNP half-life or due to a more 
active nuclear role of CASC3 in RNP biogenesis and function.  
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Translation and mRNA decay kinetics impacts alternate EJC bound mRNA pools  
As EJCs are disassembled during translation (Dostie and Dreyfuss, 2002; Gehring et 
al., 2009b), abundant RNPS1 and CASC3 footprints at EJC deposition sites suggest 
that the bulk of mRNPs undergo the compositional switch before translation. To test 
how translation impacts occupancy of both alternate EJCs, and if their occupancy is 
influenced by rate at which mRNAs enter translation pool, we obtained RNPS1- and 
CASC3-EJC footprints from cells treated with cycloheximide (CHX), and compared 
them to alternate EJC footprints from untreated cells. When mRNAs bound to each 
alternate EJC are compared across the two conditions, CASC3 RNA occupancy shows 
a dramatic change (Figure 5A). In contrast, while changes in RNPS1-bound RNAs 
across two conditions shows the same trend as CASC3 (R2=0.27, Figure 5A), the 
change is much less dramatic with RNPS1 occupancy changing significantly only on a 
handful of transcripts. These observations further support our conclusion that the 
RNPS1-bound form of the EJC precedes the CASC3-bound form. They also indicate 
that translation inhibition does not interfere with the compositional switch from RNPS1 
to CASC3 but leads to accumulation of CASC3-bound mRNPs. 
It is expected that poorly translated or translationally repressed mRNAs will be 
enriched in CASC3-EJC under normal conditions, and more efficiently translated 
mRNAs will be differentially enriched upon translation inhibition.  To test this hypothesis, 
we obtained mRNA translation efficiency (TE) estimates based on ribosome footprint 
counts for each transcript normalized to its abundance from a human colorectal cancer 
cell line (Kiss et al., 2017). A comparison of the CASC3-EJC enriched transcripts from 
the two conditions however showed only a minor difference in their median TE (Figure 
S5A). A search for functionally related genes in the two sets revealed that each contains 
diverse groups (Figure 5B). Among the transcripts differentially bound to CASC3-EJC 
under normal conditions, the largest and most significantly enriched group encodes 
signal-peptide bearing secretory/membrane bound proteins (Figure 5B), which has a 
significantly higher TE as compared to all transcripts (Figure S5B). We reason that 
despite the higher TE of the “secrotome” (all secreted/membrane proteins as classified 
in (Jan et al., 2014)), transcripts with signal peptide may be enriched in CASC3-EJC 
because binding of the hydrophobic signal peptide to the signal recognition particle halts 
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translation, which resumes only when the ribosome engages with the endoplasmic 
reticulum (ER) (Walter and Blobel, 1981). Presumably, the time before translation 
resumption on the ER allows capture of mRNPs where EJC composition has switched 
but the complex has not yet been disassembled by translation. When we excluded the 
secretome and considered only those transcripts that are translated in the cytosol (as 
defined in (Chen et al., 2011)), a comparison of TE of CASC3-EJC enriched transcripts 
under translation conducive and inhibitory conditions confirmed our initial hypothesis. As 
seen in Figure 5C, transcripts bound to CASC3-EJC in the absence of CHX have 
significantly lower median TE (-2.56) as compared to median TE of transcripts bound to 
CASC3-EJC in the presence of CHX (-2.08, p=2.7 x 10-4).   
Another functional group enriched in CASC3-EJC under normal conditions 
comprises the ribosomal protein (RP)-coding mRNAs (Figure 5B). Strikingly, transcripts 
encoding ~50% of all cytosolic ribosomal subunit proteins as well as 13 mitochondrial 
ribosome subunits are among this set (Figure 5A). Although RP mRNAs are among the 
most highly translated in the cell, a sizeable fraction of RP mRNAs are known to exist in 
a dormant untranslated state that can enter the translation pool upon demand (Geyer et 
al., 1982; Meyuhas and Kahan, 2015; Patursky-Polischuk et al., 2009). Consistently, RP 
mRNAs have significantly low TE in human and mouse cells (Figures S5B and S5C). 
Furthermore, when transcripts differentially bound to RNPS1- versus CASC3-EJC are 
directly compared in normally translating cells, RP mRNAs are specifically enriched 
among CASC3-EJC bound transcripts (Figure 5D). Therefore, RP mRNPs, and perhaps 
other translationally repressed mRNPs, that linger in the untranslated state in the 
cytoplasm switch to and persist in the CASC3-bound form of the EJC. Such a possibility 
is further supported by significantly lower TE of CASC3-EJC enriched RNAs as 
compared to RNPS1-EJC bound transcripts under normal conditions (Figure 5E). 
Further, when mRNPs are forced to persist in an untranslated state upon CHX 
treatment, cytosol translated mRNAs show increased CASC3 occupancy whereas their 
RNPS1 occupancy is not affected (Figure S5D). 
 As previously reported (Hauer et al., 2016), RP mRNAs are depleted of CASC3-
EJC upon translation inhibition (Figures 5A and 5D). Upon cycloheximide treatment, 
CASC3 occupancy is significantly reduced at canonical EJC sites of RP mRNAs as 
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compared to non-RP mRNAs, which show an increase in CASC3 occupancy (Figure 
5F, p=2.5x10-43). In comparison, RNPS1 occupancy on all transcripts modestly 
increases upon translation inhibition (Figure 5F, p=0.059). A paradoxical possibility is 
that the untranslated reserves of RP mRNAs may undergo translation when the cellular 
pool of free ribosomes is dramatically reduced upon CHX-mediated arrest of translating 
ribosomes on mRNAs. Intriguingly, a recent study in fission yeast found a similar 
contradictory increase in ribosome footprint densities on RP mRNAs upon 
cycloheximide treatment (Duncan and Mata, 2017). 
The alternate EJC occupancy landscape is also impacted by mRNA decay 
kinetics. CASC3-EJC enriched RNAs have longer half-lives as compared to RNPS1-
EJC enriched transcripts under both translation conducive (median t1/2=4.6 hr vs. 5.9 hr, 
p=3.1x10-3) and inhibitory conditions (median t1/2=3.4 hr vs. 4.8 hr, p=5.3x10-5, Figure 
5G). Notably, RNAs enriched in both alternate EJCs upon CHX treatment have lower 
half-lives as compared to the corresponding cohorts enriched from normal conditions. 
Thus, EJC detection is enhanced on transcripts that are stabilized after CHX treatment. 
Such a conclusion is further supported by enrichment of functionally related groups of 
genes known to encode unstable transcripts (e.g. cell cycle, mRNA processing and 
DNA damage, (Schwanhäusser et al., 2011)) in CASC3-EJC upon translation inhibition 
(Figure 5B).      
 
RNPS1 is required for efficient NMD of all transcripts whereas CASC3 is 
dispensable for many 
Our data suggests that mRNPs arrive in the cytoplasm with RNPS1 and SR protein-
containing EJCs, which are remodeled into CACS3-containing EJCs. We wanted to 
determine if alternate EJCs were equally important for NMD and/or if they have distinct 
targets as previously suggested (Gehring et al., 2005). In HEK293 cells with ~80% of 
RNPS1 mRNA and proteins depleted, a majority of endogenous NMD targets tested are 
significantly upregulated (Figures 6A and S6A). Surprisingly, however, in cells with 
~85% of CASC3 depleted, NMD targets are largely unaffected; some others are only 
modestly upregulated, and only one out of thirteen is significantly upregulated. Notably, 
the RNAs that were upregulated upon CASC3 depletion are even more upregulated 
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upon RNPS1 depletion. Most tested RNAs are significantly upregulated upon depletion 
of EIF4A3 and the central NMD factor UPF1 (Figure 6A and data not shown). These 
data suggest that RNPS1 function is required for efficient NMD of most endogenous 
NMD substrates whereas CASC3 may be needed for NMD of only select RNAs. 
It is possible that the residual amount of CASC3 after its siRNA mediated 
depletion is sufficient to support NMD. To test this further, we depleted endogenous 
EIF4A3 protein to ~50% of its normal levels and supplemented cells with either a WT 
EIF4A3 (WT) or an EIF4A3 mutant (YRAA: Y205A, R206A) with much reduced CASC3 
binding (Figures 6B, S6B, S6C, S6D, (Andersen et al., 2006; Ballut et al., 2005; Bono et 
al., 2006). The EIF4A3 knockdown results in >2-fold upregulation of all NMD targets 
tested (Figure 6B). We find that complementation of EIF4A3 knockdown cells with 
exogenous FLAG-EIF4A3 or FLAG-EIF4A3 YRAA proteins leads to nearly identical 
effect on NMD restoration (Figure 6B). Based on the degree of rescue, the NMD targets 
tested can be divided into two groups. The first group (to the left of vertical red dotted 
line in Figure 6B) shows a strong rescue of NMD upon complementation with both the 
wild-type or the mutant EIF4A3 proteins. Therefore, this group of transcripts can 
undergo NMD largely independent of CASC3. In the second group (to the right of 
vertical red dotted line in Figure 6B), neither the wild-type nor the mutant proteins can 
rescue NMD defect caused by the depletion of endogenous EIF4A3 protein. We noted 
that, unlike the first group (with exception of C1orf37), the second group is somewhat 
more sensitive to depletion of CASC3 (Figure 6A). This subset of mRNAs may have a 
more complex dependence on EIF4A3 levels.  
In contrast to most endogenous NMD substrates, we found that knockdown of 
both RNPS1 and CASC3 in HeLa cells leads to accumulation of a well-known β-globin 
mRNA with a premature stop codon at codon 39 (β39, Figures 6C and S6E). 
Consistently, recent genome-wide screens have identified CASC3 as an effector of 
NMD of exogenous reporters (Alexandrov et al., 2017; Baird et al., 2018). Overall, our 
results show that, in human cells, several NMD targets can undergo CASC3 
independent NMD whereas almost all tested transcripts depend on RNPS1 for their 
efficient NMD. On the other hand, exogenously (over) expressed NMD substrates may 
depend on both sequential EJC compositions for their efficient NMD.  
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Increased CASC3 levels slow down NMD 
We next tested if overexpression of RNPS1 or CASC3 can tilt EJC composition toward 
one of the two alternate EJCs, and if such a change can impact NMD. CASC3 
overexpression in HEK293 cells leads to several fold increase in CASC3 co-IP with 
EIF4A3 (Figures 7A, 7B) and RBM8A (Figures S7A and S7B), although no concomitant 
decrease is seen in RNPS1 co-precipitation with EJC core proteins. Consistent with 
this, manifold overexpression of RNPS1 did not cause any detectable change in levels 
of the two alternate factors in the EJC core IPs (Figures 7A, 7B and S7A and S7B). 
These results rule out a simple, direct competition between the two proteins for EJC 
core interaction. We next tested if increased CASC3 association with EJCs under 
elevated CASC3 levels affects NMD. Surprisingly, more than half of tested endogenous 
NMD targets are significantly upregulated upon CASC3 overexpression (Figure 7C). 
Similarly, the β39 mRNA exogenously expressed in HeLa cells is also modestly 
stabilized upon CASC3 overexpression (Figure 7D and S7C). As previously reported 
(Viegas et al., 2007), RNPS1 overexpression further downregulates β39 mRNA in HeLa 
cells (Figures S7C and S7D), indicating that NMD of this RNA occurs more efficiently 
when it is associated with early acting SR-rich EJC. 
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DISCUSSION 
The EJC is a cornerstone of all spliced mRNPs, and interacts with upwards of 50 
proteins to connect the bound RNA to a wide variety of post-transcriptional events. The 
EJC is thus widely presumed to be “dynamic”. By purifying EJC via key peripheral 
proteins, we demonstrate that a remarkable binary switch occurs in EJC’s complement 
of bound proteins. Such an EJC composition change has important implications for 
mRNP structure and function including mRNA regulation via NMD (Figure 7E).  
  
EJC composition and mRNP structure 
Our findings suggests that when EJCs first assemble during co-transcriptional splicing, 
the core complex consisting of EIF4A3, RBM8A and MAGOH engages with SR proteins 
and SR-like factors including RNPS1 (Figure 2). Within these complexes, RNPS1 is 
likely bound to both the EJC core as well as to the SR and SR-like proteins bound to 
their cognate binding sites on the RNA (Figure 3). This network of interactions bridges 
adjacent and distant stretches of mRNA, winding the mRNA up into a higher-order 
structure, which is characteristic of RNPs purified from human cells via the EJC core 
proteins or RNPS1 (Figure 2, (Singh et al., 2012)). Such higher-order mRNA packaging 
can create a compact RNP particle for its efficient intracellular transport. It is possible 
that assembly of these higher-order structures occur via multiple weak interactions 
among low complexity sequences (LCS) within EJC bound SR and SR-like proteins 
(Haynes and Iakoucheva, 2006; Kwon et al., 2014). It also remains to be tested if 
RNPS1, which possesses an SR-rich LCS, acts as a bridge between the EJC core and 
more distantly bound SR proteins. Our data also indicates that on a majority of mRNPs, 
these SR-rich and RNPS1-containing higher-order EJCs persist throughout their nuclear 
lifetime (Figure 4). When mRNPs arrive in the cytoplasm, the SR and SR-like proteins 
are evicted from all EJCs of an mRNP and the EJC is joined by CASC3 (Figure 4). It 
remains to be seen if CASC3 incorporation into an EJC causes its remodeling. 
Alternatively, active process(es) such as RNP modification via SR protein 
phosphorylation by cytoplasmic SR protein kinases (Zhou and Fu, 2013) or RNP 
remodeling by ATPases may precede CASC3 binding to EJC (Lee and Lykke-
Andersen, 2013). What is clear is that CASC3-bound EJCs lose their higher order 
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structure and exist as monomeric complexes at the sites where EJC cores were co-
transcriptionally deposited. Thus, the switch in EJC composition from RNPS1 and SR-
rich complexes to CASC3-bound complexes leads to a striking alteration in higher-order 
EJC, and possibly, mRNP structure (Figure 7E). The CASC3 bound form of the EJC 
following compositional switch is the main target of translation dependent disassembly 
although RNPS1-EJC may undergo some translation-dependent disassembly (Figure 
5).   
  
CASC3-EJC and pre-translation mRNPs 
Our findings support the emerging view that CASC3 is not an obligate component of all 
EJC cores. A population of assembled EJCs, especially those early in their lifetime, 
completely lack CASC3 (Figures 1 and 2). Such a view of partial CASC3 dispensability 
for EJC structure and function is in agreement with findings from Drosophila where the 
assembled trimeric EJC core as well as RNPS1 and its partner ACIN1 are required for 
splicing of long or sub-optimal introns whereas CASC3 is not (Hayashi et al., 2014; 
Malone et al., 2014; Roignant and Treisman, 2010). A recent report that lack of CASC3 
during mouse embryonic brain development results in phenotypes distinct from those 
caused by similar mutations of the other three core proteins also supports non-
overlapping functions of CASC3 and the other core factors (Mao et al., 2017). We note 
that in the recently reported human spliceosome C* structure, CASC3 is bound to the 
trimeric core (Zhang et al., 2017). As the spliceosomes described in these structural 
studies were assembled in vitro in nuclear extracts, it is possible that CASC3 present in 
extracts can enter pre-assembled spliceosomes and interact with EJC. Consistently, in 
the human spliceosome C* structure one of the two CASC3 binding surfaces on EIF4A3 
is exposed and available for CASC3 interaction. Still, a possibility remains that, at least 
on some RNAs or exon junctions, CASC3 assembly may occur soon after splicing 
within peripseckles as previously suggested (Daguenet et al., 2012).  
CASC3 is a more prominent component of cytoplasmic EJCs within mRNPs that 
have not yet been translated or are undergoing their first round of translation (Figure 5). 
Previously described functions of CASC3 within translationally repressed neuronal 
transport granules (Macchi et al., 2003) and posterior-pole localized oskar mRNPs in 
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Drosophila oocytes (van Eeden et al., 2001) further support CASC3 being a component 
of cytoplasmic pre-translation mRNPs. It remains to be tested if, like its active role in 
oskar mRNA localization and translation repression (van Eeden et al., 2001), CASC3 
also plays a direct role in translational quiescence of RP mRNAs and/or their 
mobilization to rapidly meet increased demand for translation apparatus (Geyer et al., 
1982; Patursky-Polischuk et al., 2009). Nonetheless, our results emphasize the idea of 
post-transcriptional regulons wherein mRNPs encoding functionally related activities are 
under coordinated translational control. Capture of such regulons via CASC3-EJC 
highlights a potential utility of EJC as a molecular marker to identify coordinately 
translated regulons, perhaps as a complementary approach to the recently described 
translation-dependent protein knock-off to monitor first round of translation of single 
mRNPs (Halstead et al., 2015). 
 
EJC composition and NMD 
Based on the binary EJC composition switch, EJC-dependent steps in the NMD 
pathway can be divided into at least two phases wherein the two alternate factors 
perform distinct functions. The susceptibility of all tested NMD targets to RNPS1 levels 
suggests that this protein, and perhaps other components of SR-rich EJCs, serve a 
critical function in an early phase in the pathway. Such a function could be to recruit 
and/or activate other EJC/UPF factors either in the nucleus or even during premature 
translation termination as part of the downstream EJC. Following the compositional 
switch, the EJC core maintains the ability to activate NMD as it can directly 
communicate with the NMD machinery via UPF3B (Buchwald et al., 2010; Chamieh et 
al., 2008). Still, following CASC3 incorporation into the EJC, its ability to stimulate NMD 
is likely reduced. Such a reduction may stem from the loss of RNPS1 or SR proteins, 
which are known to enhance NMD (Figure S7, (Aznarez et al., 2018; Sato et al., 2008; 
Viegas et al., 2007; Zhang and Krainer, 2004)). It is possible that CASC3 
overexpression causes the compositional switch to occur at a faster rate or on a greater 
proportion of mRNAs, or both. Nevertheless, (over)expressed NMD reporters (e.g. β39 
mRNA) and some endogenous mRNAs depend on both early and late EJC 
compositions for their NMD. Notably, the β-globin NMD reporter was previously shown 
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to undergo biphasic decay with faster turnover around the nuclear periphery and slower 
decay in more distant cytoplasmic regions (Trcek et al., 2013). More recently, single-
molecule imaging of reporter RNPs showed that a fraction of their population diffuses 
for several minutes and micrometers away from the nucleus before undergoing first 
round of translation (Halstead et al., 2015). It remains to be seen if mRNPs that are first 
translated in distant cytoplasmic locales, including those localized to specialized 
compartments such as neuronal dendrites and growth cones, may rely more on a 
CASC3-dependent slower phase of NMD. The EJC compositional switch may also 
underlie the distinct NMD branches identified earlier via tethering of RNPS1 and CASC3 
to reporter mRNAs (Gehring et al., 2005). Consistent with these observations, we find 
that RNPS1 co-purifies more strongly with UPF2, while CASC3 appears to interact more 
with UPF3B (Figure 2 and data not shown). The nature of the relationship between EJC 
composition and UPF2 and UPF3B-independent NMD branches is an important avenue 
for the future work.  
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Figure 1. RNPS1 and CASC3 exists in mutually exclusive EJCs in mammalian cells.  
(A) Alternate EJCs in HEK293 cells. Western blots showing proteins on the right in 
total cell extract (T) (lane 1) or the immuno-precipitates (IP) (lanes 2-5) of the 
antibodies listed on the top. The asterisk (*) indicates signal from IgG heavy 
chain. 
(B) Alternate EJCs in mouse cortical total extracts and IPs as in (A).   
(C) Confirmation of mutually exclusive interactions via bottom-up proteomics. 
Heatmap showing signal for normalized-weighted spectra observed for the 
proteins on the right in the indicated FLAG IPs (top). The color scale for log2 
transformed normalized-weighted spectral values is shown below. 
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Figure 2. CASC3- and RNPS1-containing complexes have distinct protein composition 
and hydrodynamic size. 
(A) Comparison of alternate EJC proteomes-I. A scatter plot where log2 transformed 
values are compared for fold-enrichment of proteins in FLAG-RNPS1 IP over 
FLAG-only control (x-axis) to fold-enrichment of the same proteins in FLAG-
CASC3 IP over FLAG-only control (y-axis). Protein quantification was performed 
using Normalized Spectral Abundance Factor (NSAF). Each dot represents a 
protein that was identified in FLAG-EJC or FLAG-only control samples by 
Scaffold (see experimental procedures). Black dots: proteins enriched >2-fold 
over control in the FLAG-Magoh IP. 
(B) Comparison of alternate EJC proteomes-II. A heatmap showing proteins that are 
>10-fold enriched in any of the FLAG-EJC IPs (indicated on the top) over FLAG-
only control (proteins deemed to be contaminants were omitted). Proteins are 
grouped according to common functions (right). The color scale for the heatmap 
is at the bottom. 
(C) Validation of mass spec. Western blots showing proteins (right) in total extract (T) 
or FLAG-IPs as on the top from HEK293 cells stably expressing FLAG-tagged 
proteins indicated on the top left. Note that RNPS1 migrates just above EIF4A3. 
The asterisk (*) indicates cross-reaction with CASC3 observed with anti-ACIN1 
antibody. 
(D) Hydrodynamic sizes of the alternate EJCs. Western blots showing proteins on 
the right in glycerol gradient fractions of FLAG-IPs from HEK293 cells stably 
expressing FLAG-MAGOH, FLAG-RNPS1, or FLAG-CASC3 (far left). The 
position of fractions from gradients (top) and molecular weight standards are 
indicated (bottom).  
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Figure 3. RNPS1 assembles with canonical and non-canonical EJCs but CASC3 is 
mainly part of canonical EJCs. 
(A) A schematic illustrating main steps in RNA:protein Immunoprecipitation in 
Tandem (RIPiT)-Seq. 
(B) Genome browser screen-shots comparing read coverage along the ISYNA1 
gene in RNA-Seq or RIPiT-Seq libraries (indicated on the right). The y-axis of 
each track in this window was normalized to millions of reads in each library. 
Blue rectangles: exons; thinner rectangles: untranslated regions; lines with 
arrows: introns. 
(C) Meta-exon plots showing read depth in different RIPiT-Seq or RNA-Seq libraries 
(indicated in the middle) in the 150 nucleotides (nt) from the exon 5’ end (left) or 
from the exon 3’ end (right). The vertical black dotted line marks the -24 nt 
position previously determined to be the site of canonical EJCs (Singh et al., 
2012). 
(D) A composite plot of RNPS1 and CASC3 RIPiT-Seq footprint read 5’ (solid lines) 
and 3’ (dotted lines) ends. The canonical EJC site (-24 nt) is indicated by the 
vertical dotted line. Note there is some variability in the 5’ boundary of EJCs 
whereas the 3’ boundary is more strict (indicated by the vertical grey line at the -
19 position).   
(E) Box plots showing frequencies of 6-mers that contained CG 3-mers (CGG, GCG, 
CCG, CGC) or GA 3-mers (GGA, GAA, AGG, GAG) in CASC3 or RNPS1 RIPiT-
Seq reads. Top: p-values based on Wilcoxon rank-sum test. 
(F) Cumulative distribution function plots showing frequency of reads in the indicated 
samples with the highest score for match to SRSF1 motif (inset) position weight 
matrix (PWM). Sample identity is in the legend on the bottom left. The SRSF1 
motif shown in the inset is from (Tacke and Manley, 1995).  
(G) A negative binomial based assessment of significance of differences in SRSF1 
motif PWM scores in (F) between the two alternate EJC footprint reads or 
between alternate EJC and RNA-Seq reads (legend on the bottom left). The 
horizontal dotted red line indicates p=0.05 whereas the horizontal solid red line 
indicates the Bonferroni adjusted p-value.  
A
Figure 4
C
B
0.1 10 1000
ï
0

Mean of normalized counts
log
2 f
old
-c
ha
ng
e
Unenriched genes
Genes enriched in RNPS1-EJC 
Genes enriched in CASC3-EJC 
323 555
&$6&í(-&
5136í(-&
Genes with 2+ significantly occupied exons
D
Pe
rc
en
t C
yto
pla
sm
ic 
ab
un
da
nc
e
All transcripts
(n= 10738)
&$6&ï(,)$
Q 
5136ï(,)$
Q 
0.0
0.2

0.6
0.8
1.0
S [ï E
2 kb
RNA-Seq
1&%,5HI6HTJHQHV
&$6&(,)$[O$
&$6&(,)$[O%
5136(,)$[O$
5136(,)$[O%
0$*2+(,)$
656)
_
0 _
18.2 _
0 _
7.8_
0 _
_
0 _
_
0 _
_
0 _
Re
ad
s p
er
 m
illi
on
F
10 kb
RNA-Seq
1&%,5HI6HTJHQHV
&$6&(,)$[O$
&$6&(,)$[O%
5136(,)$[O$
5136(,)$[O%
0$*2+(,)$
;,67
67.1_
0 _
B
0 _
689.9_
0 _
962.1_
0 _
B
0 _
B
0 _
Re
ad
s p
er
 m
illi
on
ï
ï
ï
ï
0
1
2

All genes
(n= 10737)
',
Q 
',
(n= 389)
log
2 f
old
-c
ha
ng
e
S [ï
S [ï
S [ï
0.221

S [ï
S [ï
0.76

0.63
S[-37
Figure 4. RNPS1 and CASC3 occupy same RNAs and sites but in different subcellular 
compartments. 
(A) A venn-diagram showing genes with at least two differentially enriched exons, for 
which all differentially enriched exons are preferentially bound to CASC3-EJC 
(blue region), RNPS1-EJC (orange region), or genes with at least one exon is 
enriched in CASC3-EJC and one in RNPS1-EJC (overlap region). (p < 2.8 x 10-
37). p-value shown was obtained as the probability of observing an overlap of 5 or 
fewer genes using a binomial distribution approximating each gene as containing 
two exons. 
(B) An MA-plot showing fold-change in RNPS1-EJC versus CASC3-EJC footprint 
reads (y-axis) against expression levels (x-axis). Each dot represents a canonical 
transcript for each known gene in GRChg38 from UCSC “knownCanonical” splice 
variant table. Transcripts determined to be differentially enriched (p-
adjusted<0.05) in RNPS1-EJC (orange) and CASC3-EJC (blue) are indicated.  
(C) Box plots showing distribution of percent cytoplasmic levels (y-axis) for all (grey), 
CASC3-EJC enriched (blue), and RNPS1-EJC enriched (orange) transcripts. The 
median values are given to the right of each box plot. p-values on the top are 
based on Wilcoxon rank sum test. Bottom: The number of transcripts in each 
group. 
(D) Box plots showing distribution of fold-change values (y-axis) for RNPS1-EJC 
versus CASC3-EJC footprint read counts for all (grey), detained intron-containing 
(DI+; yellow) or detained intron-lacking (DI-; green) transcripts. (+ve values: 
enriched in RNPS1-EJC; -ve values: enriched in CASC3-EJC). Top: p-values 
(Wilcoxon rank sum test). Bottom: the number of transcripts in each group. 
(E) Genome browser screen-shots showing read coverage along the SRSF5 gene in 
RNA-Seq (top) or RIPiT-Seq libraries (labeled on right). Blue rectangles: exons; 
thinner rectangles: untranslated regions; lines with arrows: introns. Note 
increased RNA-Seq reads in introns 4 and 5. 
(F) Genome browser screen-shot as in (E) for the XIST locus. 
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Figure 5. Translation and mRNA decay kinetics impacts alternate EJC occupancy. 
(A) A scatter plot showing fold-change in CASC3-EJC occupancy in absence versus 
presence of cycloheximide (CHX; x-axis) and fold-change in RNPS1-EJC in 
absence versus presence of CHX (y-axis). Each dot represents a canonical 
transcript for each known gene in GRChg38, and is colored as indicated in the 
legend (bottom right). The dots representing ribosomal protein genes are 
highlighted by a green outline. The dotted red line shows a linear fit and the 
coefficient of determination (R2) is on the top left corner. 
(B) Top 5 GO term keywords and their log10 transformed p-values of enrichment in 
CASC3-EJC enriched transcripts (from A) in the absence (left) or presence of 
CHX (right). 
(C) Box plots showing distribution of translation efficiency estimates (y-axis) of 
transcript groups on y-axis. The median values are given to the right of each box 
plot. Top: p-values (Wilcoxon rank sum test). Bottom: the number of transcripts in 
each group. 
(D) Scatter plot as in (A) comparing fold-change in CASC3-EJC versus RNPS1-EJC 
footprint read counts in -CHX (x-axis) and +CHX (y-axis) conditions.  
(E) Box plots as in (C) showing distribution of translation efficiency estimates of 
transcript groups from (D) as indicated on the bottom.  
(F) Comparison of fold-change in CASC3-EJC or RNPS1-EJC footprint reads at 
canonical EJC sites (as defined in the methods section) from ribosomal protein 
(RP)-coding mRNAs or non-ribosomal (non-RP)-protein coding mRNAs. Top: p-
values (Wilcoxon rank sum test). 
(G) Box plots as in (C) and (E) above comparing mRNA half-life of transcript groups 
from (D) as indicated on the bottom. 
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Figure 6. RNPS1 is required whereas CASC3 is largely dispensable for efficient NMD. 
(A) Fold change as measured by real-time PCR in abundance of endogenous NMD-
targeted transcripts (bottom) in HEK293 cells depleted of core or alternate EJC 
factors. (EIF4A3 knockdown: 48 hr, alternate EJC factor knockdown: 96 hr). 
Shown are the average values normalized to TBP levels from three biological 
replicates ± standard error of means (SEM). Asterisks denote statistically 
significant differences: * p<0.05, ** p<0.01, *** p<0.001 (Welch’s t-test). Percent 
knockdown of each protein in a representative experiment is in the legend (see 
Figure S6). 
(B) Real-time PCR analysis as in (A) from HEK293 cells depleted of EIF4A3. Either 
wild-type EIF4A3 or a mutant lacking CASC3 interaction were exogenously 
expressed in EIF4A3 knockdown cells as indicated in the legend on the top right. 
Inset: An EJC core crystal structure (PDB ID: 2J0S) showing the EIF4A3 
residues that interact with CASC3 (enlarged below). The vertical red dotted line 
divides the NMD targets into two groups based on the degree of NMD 
restoration. 
(C) Northern blots showing levels of wild-type (βwt, lane 1) or PTC-containing (codon 
39; β39; lanes 2-5) β-globin mRNA and a longer internal control β-globin (βUAC-
GAP) mRNA from HeLa Tet-off cells treated with siRNAs indicated on the top. 
Tables below indicate percentage of normalized β39 mRNA as compared to 
normalized βwt mRNA (top) or fold-increase in β39 mRNA upon knockdown as 
compared to control.  
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Figure 7. Promotion of switch to late-acting CASC3-EJC dampens NMD activity. 
(A) Western blots showing proteins on the right in total extract (T, lanes 1-3) or 
EIF4AIII IPs (lanes 4-6) from HEK293 cells overexpressing FLAG-fusion proteins 
at top left.   
(B) Histogram showing the fold enrichment of alternate EJC factors in EIF4A3 IPs 
from (A). Overexpressed (OE) alternate EJC factors are at the bottom and 
CASC3 (blue) and RNPS1 (orange) levels in each OE sample (lane 5 or 6) were 
compared to the control IP in lane 4 (grey, set to 1).  
(C) Fold change in abundance of NMD-targeted endogenous transcripts (bottom) in 
HEK293 cells exogenously overexpressing FLAG or FLAG-CASC3. Shown are 
the average values normalized to ACTB levels from three biological replicates ± 
SEM. Asterisks denote statistically significant differences: * p<0.05, ** p<0.01, *** 
p<0.001 (Welch’s t-test). 
(D) Northern blots showing decay of Tetracycline-inducible β39 mRNA as compared 
to constitutively expressed βUAC-GAP mRNA in HeLa Tet-off cells 
overexpressing FLAG-tagged proteins indicated on the left. Time after Tet-
mediated transcriptional shut-off of β39 mRNA is indicated on the top. On the 
right is β39 mRNA half-life (t1/2) from each condition (average of three biological 
replicates ± standard deviation). 
(E) A model depicting switch in EJC composition and its effect on mRNP structure 
and NMD activity. Key EJC proteins are indicated. Oval with radial blue fill in the 
high molecular weight (HMW) EJCs represent unknown interactions that mediate 
EJC multimerization. Grey and black lines: exons. 
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Figure S1. (related to Figure 1) 
(A) Alternate EJCs in P19 cells. Western blots showing proteins on the left in P19 
total cell extract (T, lane 1) or the immuno-precipitates (IP, lanes 2-5) using the 
antibodies listed on the top.  
(B) Alternate EJCs in HeLa cells as in (A).  
(C) Tetracycline (Tet)-induction of FLAG-tagged CASC3 and RNPS1. Western blots 
showing Tet-induced expression of FLAG-fusion proteins in FLP-In TREx Tet-on 
HEK293 cell lines. Tet concentrations are on the top, proteins detected are on 
the left and antibodies used for westerns are on the right.  
(D) Tagged proteins assemble into alternate EJCs. Western blots showing proteins 
on the left in TE or FLAG IPs of FLAG-fusion proteins expressed in HEK293 cells 
at near-endogenous levels. 
(E) Alternate EJC proteomic analysis (replicate 2). Heatmap showing enrichment of 
proteins on the right in FLAG-EJC protein IP proteomic analysis (indicated on the 
top). 
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Figure S2. (related to Figure 2) 
(A) Comparison between the two biological replicates of each FLAG-EJC mass spec 
samples. Overlap between >2-fold enriched proteins in the two biological 
replicates of proteomics samples of FLAG-EJC proteins indicated on the top. 
Hypergeometric test p-values are shown next to each venn diagram. For FLAG-
MAGOH and FLAG-RNPS1 replicates, scatter plots compare total spectral 
counts for proteins detected in the two biological replicates. The linear fits for 
proteins enriched less or more than 2-fold are shown as indicated in the legend. 
Spearman correlation coefficient for >2-fold enriched proteins in each sample is 
shown. 
(B) Comparisons as in (A) between the reproducibly enriched proteins in FLAG-
MAGOH with those enriched in both replicates of FLAG-RNPS1 (left) and FLAG-
CASC3 (right).     
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Figure S3. (related to Figure 3) 
(A) Proteins and RNAs enriched in native alternate EJC RIPiTs. Top: Western blots 
with proteins indicated on the right in TE or RIPiT elutions. Bottom: 
Autoradiogram of end labeled RNAs from RIPiT elutions as well as size-markers 
(indicated on either side). The asterisk (*) indicates detection of IgG heavy chain. 
(B) Comparison between native CASC3-EJC RIPiT-Seq samples [FLAG-
MAGOH:CASC3 (x-axis) versus FLAG-CASC3:EIF4A3 (y-axis)]. Scatter plot 
comparing read counts for canonical transcripts for each known gene in 
GRChg38 (represented by each dot). A linear fit and Spearman correlation 
coefficient are also shown. 
(C) Comparison between native RNPS1-EJC RIPiT-Seq samples [FLAG-
MAGOH:RNPS1 (x-axis) versus FLAG-RNPS1:EIF4A3 (y-axis)] as in (C). 
(D) Proteins and RNAs enriched in formaldehyde-crosslinked alternate EJC RIPiTs 
as in (A). 
(E) Comparison as in (C) between native and formaldehyde-crosslinked CASC3-EJC 
RIPiT-Seq samples [FLAG-CASC3:EIF4A3, formaldehyde-crosslinked (xl), 
replicate A (x-axis) versus native FLAG-CASC3:EIF4A3 (y-axis)]. 
(F) Comparison as in (C) between native and formaldehyde-crosslinked RNPS1-EJC 
RIPiT-Seq samples [FLAG-RNPS1:EIF4A3, formaldehyde-crosslinked (xl), 
replicate A (x-axis) versus native FLAG-RNPS1:EIF4A3 (y-axis)]. 
(G) Comparison as in (C) between two replicates of the formaldehyde-crosslinked 
CASC3-EJC RIPiT-Seq samples [FLAG-CASC3:EIF4A3-xl, replicate B (x-axis) 
versus FLAG-CASC3:EIF4A3-xl, replicate A (y-axis)]. 
(H) Comparison as in (C) between two replicates of the formaldehyde-crosslinked 
RNPS1-EJC RIPiT-Seq samples [FLAG-RNPS1:EIF4A3-xl, replicate B (x-axis) 
versus FLAG-RNPS1:EIF4A3-xl, replicate A (y-axis)]. 
(I) Normalized read densities in alternate EJC footprint libraries in the genomic 
region indicated at the bottom. Each box plot comprises values from all eight 
RIPiT-Seq datasets listed in Table S2. Top: p-values (Wilcoxon rank sum test). 
(J) Meta-exon plots showing read depth in different RIPiT-Seq or RNA-Seq libraries 
(top left corner) in the 150 nucleotides (nt) from the exon 3’ end.  
(K) Distribution of exon mapping reads among the exonic regions indicated on top in 
the RIPiT-Seq libraries (bottom). 
(L) Cumulative distribution function plots showing frequency of reads in the indicated 
samples with the highest score for match to PWM for SRSF9 motif (inset, top 
right). Bottom left: sample identity. The SRSF9 motif shown in the inset is from 
(Paradis et al., 2007).  
(M) A negative binomial based assessment of significance of differences in SRSF9 
motif PWM scores in (L) between reads from samples in the legend on the 
bottom left. Horizontal dotted red line: p=0.05; Horizontal solid red line: 
Bonferroni adjusted p-value. 
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Figure S4. (related to Figure 4) 
(A) Comparison of read counts from both cross-linked replicates of CASC3-EJC (x-
axis) versus RNPS1-EJC (y-axis). Each dot on the scatter plot represents each 
exon in the knownCanonical transcript annotation for UCSC known genes. A 
linear fit and coefficient of determination (R2) are shown. 
(B) Comparison of read counts from both cross-linked replicates of CASC3-EJC (x-
axis) versus RNPS1-EJC (y-axis). Each dot on the scatter plot represents 
knownCanonical transcript for UCSC known genes. A linear fit and coefficient of 
determination (R2) are shown. 
(C) RNA dependent and independent interactions between EJC proteins. Western 
blots of proteins on the right in total extracts (T) or FLAG immunoprecipitates (IP) 
from HEK293 cells expressing FLAG-tagged proteins on the top. Inclusion of 
RNase A in extracts during IP is indicated on top of each lane. 
(D) Relative alternate EJC levels versus nuclear abundance of long non-coding 
RNAs (lncRNAs). Each dot on the scatter plot represents knownCanonical 
transcript with spliced lncRNAs labeled in black. CASC3 or RNPS1-enriched 
transcripts are colored as in the legend (bottom right). x-axis: -ve fold-change= 
CASC3-enrichment,  +ve fold-change= RNPS1-enrichment. 
(E) Subcellular fractionation. Western blots for proteins on the right in total extracts 
(T), cytoplasmic (C), or nuclear (N) fractions of HEK293 cells. 
(F) Presence of alternate EJCs in cytoplasmic extracts.  Western blots for proteins 
on the right in the fractions of HEK293 cells (top). FLAG-tagged proteins 
expressed in cells are indicated above each lane.  
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Figure S5. (related to Figure 5) 
(A) Box plots showing distribution of translation efficiency estimates (y-axis) of 
transcript groups on y-axis. The median values are given to the right of each box 
plot. Top: p-values (Wilcoxon rank sum test). Bottom: the number of transcripts in 
each group. 
(B) Comparison of translation efficiency (TE, y-axis) of secrotome (red) and 
ribosomal protein (RP) transcripts (green) to all transcripts (grey). Number of 
genes in group are at the bottom. TE data from (Kiss et al., 2017). 
(C) Translation efficiency of RP genes in mouse embryonic stem cells. TE data from 
(Ingolia et al., 2011). 
(D) Box plots showing fold-change (y-axis) in alternate EJC occupancy (x-axis, at the 
bottom) for transcript groups shown at the bottom. x-axis: -ve fold-change= 
enrichment in -CHX condition,  +ve fold-change= enrichment in +CHX condition. 
The median fold-change values are given to the right of each box plot. Top: p-
values (Wilcoxon rank sum test). Bottom: the number of transcripts in each 
group.   
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Figure S6 (related to Figure 6) 
(A) Knockdowns of EJC proteins (related to Figure 6A). Western blots of EJC core 
and alternate factor siRNA-mediated knockdowns (left). Right, top: Quantification 
of knockdown efficiency of EJC protein remaining relative to HNRNPA1 protein 
levels. Right, bottom: Knockdown efficiency as determined by qPCR of EJC 
factor mRNA levels relative to ACTB mRNA levels .   
(B) Rescue of EIF4A3-depleted cells. Western blots for proteins on the right from 
HEK293 cells depleted of EIF4A3 and expressing either wild-type EIF4A3 or a 
mutant EIF4A3 lacking CASC3 interaction as indicated on the top. 
(C) Interaction of EIF4A3-YRAA with CASC3. Western blots showing proteins on the 
right in total extract or FLAG IPs from HEK293 cells expressing FLAG-tagged 
proteins on the top along with MYC-CASC3, -RNPS1, and -HNRNPA1. The 
asterisk indicates cross-reacting band likely to be unreduced FLAG-IgG heavy 
chain.  
(D) Quantification of western blots in (C) showing relative MYC-CASC3 (left, blue) 
and MYC-RNPS1 (right, orange) co-IP with FLAG-EIF4A3 proteins on the 
bottom.  
(E) Knockdown of EJC/UPF1 proteins (Figure 6C). Western blots showing proteins 
indicated on the left from HeLa Tet-off cells treated with siRNAs indicated on the 
top. Two technical replicates of each knockdown are shown. HNRNPA1 panel 
shown in lanes 5-6 is shown again in lanes 9-10. 
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Figure S7 (related to Figure 7) 
(A) Effect of alternate EJC factor overexpression on EJC composition. Western blots 
for proteins on the right in total extract (lanes 1-3), control IgG IP (lane 4) or 
RBM8A IPs (lanes 5-7) from HEK293 cells overexpressing (OE) FLAG-fusion 
proteins at top. Fold overexpression (FOE) on bottom is relative to protein levels 
in lane 1 after normalizing to HNRNPA1 protein levels in particular lane.  
(B) Quantification of (A) for co-IP of CASC3 (left) or RNPS1 (right) upon RBM8A IP 
from cell lines overexpressing the proteins on the bottom. Fold enrichment was 
normalized by co-purifying MAGOH levels. 
(C) Effect of alternate EJC overexpression on β-globin NMD. Northern blots showing 
levels of wild-type β-globin RNA (βwt) and an NMD-targeted β-globin RNA (β39)  
(as indicated on the top) along with co-transfected βUAC-GAP RNA from HeLa 
cells expressing alternate EJC factors (top left). % Remaining: βwt or β39 levels 
in each sample were normalized to βUAC-GAP RNA. Numbers below each lane 
show normalized β39 RNA remaining as % of normalized βwt RNA for the 
corresponding treatment (set to 100). Two independent replicates are shown.  
 
 	
Table S1. Summary of proteins identified by LC-MS/MS in the two replicates of 
FLAG-EJC and FLAG-only IPs. 	
#Alternate EJC_replicate1 
341 proteins at 99% minimum, 2 minimum peptides, 0.0% decoy FDR;; 9540 spectra at 
95% minimum, 0.00% decoy FDR 
From proteins clusters, only member proteins with a non-zero value in at least one 
sample were retained  
Normalized spectral abundance factor (NSAF) values from Scaffold were used for 
quantitation; a psuedo count of 0.000001 was added to each NSAF value before 
determining enrichment in EJC IPs as compared to FLAG-only 
Proteins enriched >2-fold in any of the three EJC IPs over FLAG-only IP are shown 
    
 log2(NSAF) 
Accession Number MAGOH CASC3 RNPS1 
SAP18_HUMAN 12.12344246 9.600730633 13.95255926 
LC7L2_HUMAN 10.76661172 0 12.67785175 
SRSF1_HUMAN 9.42840205 8.905056005 11.86905398 
H4_HUMAN 12.27926234 12.49192823 11.75826486 
SRSF6_HUMAN 11.27676417 0 11.69657638 
PR40A_HUMAN 11.06379952 0 11.54245153 
SCML1_HUMAN 0 0 11.46142829 
PRP4B_HUMAN 11.4926043 0 11.23463783 
RBM25_HUMAN 10.46954007 0 11.04753294 
GPTC8_HUMAN 8.417008587 0 10.96275144 
SNIP1_HUMAN 0 0 10.95325069 
SRSF7_HUMAN 9.487699374 0 10.81338039 
TRA2A_HUMAN 10.24210228 0 10.79100005 
PPIG_HUMAN 8.82527683 0 10.73479428 
DDX41_HUMAN 10.10105646 0 10.64988486 
CWC22_HUMAN 10.55487659 0 10.10446771 
SRS10_HUMAN 9.349303347 0 10.09037711 
CRNL1_HUMAN 9.654385415 0 9.980853606 
MGN_HUMAN 12.77585716 12.25168951 9.934059395 
CATIN_HUMAN 9.81605565 0 9.879828273 
CSK21_HUMAN 0 0 9.834897633 
SRSF3_HUMAN 0 0 9.766512345 
RBM8A_HUMAN 12.93774162 11.73564064 9.681238412 
ANM1_HUMAN 8.887708033 0 9.628390857 
SRSF5_HUMAN 9.295332732 0 9.621740545 
CDK12_HUMAN 9.840982435 0 9.583195621 
RPB1_HUMAN 10.1382718 0 9.572643389 
RL6_HUMAN 10.21176665 12.0086037 9.539391485 
PGAM5_HUMAN 9.208014828 0 9.534400161 
CCNK_HUMAN 0 0 9.529430554 
SRSF4_HUMAN 8.43629512 0 9.497971558 
PLRG1_HUMAN 9.961290512 0 9.440786132 
RBM22_HUMAN 9.668034004 0 9.410281737 
ZC3HE_HUMAN 9.443979543 0 9.408329741 
SRSF9_HUMAN 0 0 9.336752009 
DHX8_HUMAN 10.1291542 0 9.331432034 
H2AY_HUMAN 9.842915995 8.321612471 9.170726276 
RU2A_HUMAN 0 0 9.130647779 
H2A1A_HUMAN 0 0 9.091646948 
RT29_HUMAN 0 0 9.073445375 
ZCH18_HUMAN 9.807709112 0 9.036201092 
SRSF8_HUMAN 0 0 8.985699652 
SPT6H_HUMAN 7.634593268 0 8.957073013 
NKTR_HUMAN 9.675904121 0 8.933572638 
CD11A_HUMAN 0 0 8.834629058 
CWC27_HUMAN 8.501837185 0 8.82791427 
DGC14_HUMAN 0 0 8.815767536 
AKP8L_HUMAN 8.050556113 0 8.790283326 
RBBP6_HUMAN 6.588219912 0 8.77778133 
FXR2_HUMAN 7.991748578 0 8.731352976 
CSK22_HUMAN 0 0 8.674721924 
HP1B3_HUMAN 9.271719795 7.75181182 8.599950025 
LUC7L_HUMAN 0 0 8.590886411 
SNUT2_HUMAN 0 0 8.569058109 
FIP1_HUMAN 8.171226847 0 8.497053445 
CMBL_HUMAN 0 12.08988078 8.190713617 
SMU1_HUMAN 9.964095343 0 8.124793379 
RS4X_HUMAN 0 9.818933622 8.088788239 
NCBP1_HUMAN 0 0 8.0869854 
PHRF1_HUMAN 9.017838416 0 8.025527183 
SRRT_HUMAN 8.609437329 0 7.938462236 
PAXB1_HUMAN 7.547434405 0 7.87276721 
RBMX_HUMAN 0 0 7.519243094 
GPTC1_HUMAN 7.525755693 0 7.269126679 
RECQ5_HUMAN 9.015526561 0 7.179610571 
PPWD1_HUMAN 10.04644195 0 6.799993888 
PININ_HUMAN 6.8673278 -6.910133013 6.25017964 
IF4A3_HUMAN 6.771047915 6.220329511 6.19106795 
DDB1_HUMAN 0 8.704906538 5.99047842 
SON_HUMAN 6.126682474 -5.179948888 5.676165346 
TCOF_HUMAN 0 7.326069892 5.61303063 
SFR19_HUMAN 5.367405791 -6.048388784 4.575401278 
SRRM1_HUMAN 4.360907368 0.470829819 4.257178256 
RNPS1_HUMAN 3.31613842 -0.526593813 4.227919599 
ACINU_HUMAN 4.051882067 -1.108281217 4.080682378 
LC7L3_HUMAN 3.797146519 -7.636334602 4.053576036 
RBM39_HUMAN 3.799733114 -8.33860269 3.82174148 
TRA2B_HUMAN 3.801634108 -9.216479117 3.594192925 
PUF60_HUMAN 1.989468646 1.466254652 3.314884359 
RPB2_HUMAN 3.56347561 -6.206428335 3.305719523 
PCBP1_HUMAN 1.992068594 2.052717845 3.192553494 
SRRM2_HUMAN 3.974038446 -2.821225465 3.167279714 
SNW1_HUMAN 1.989809969 0.46980974 3.052499512 
PRP17_HUMAN 2.573419515 -7.216260837 2.899953146 
RL3_HUMAN 2.5786637 1.470114407 2.735523603 
TR150_HUMAN 2.749709192 -9.486633935 2.409244244 
BCLF1_HUMAN 2.802239395 -9.54041868 2.26048122 
SYF1_HUMAN 2.453011539 -1.520974484 2.259183547 
U2AF2_HUMAN 0.994555861 -8.496174702 2.057358601 
GNL3_HUMAN 0.991971421 0.46977667 2.053387389 
HNRPF_HUMAN 2.575736378 2.466527005 1.733568579 
AQR_HUMAN 1.408956925 -8.436878077 1.674127144 
XRCC6_HUMAN 0.581108117 -0.941562133 1.322646441 
PRP8_HUMAN 1.132917086 -3.823514146 1.143372415 
CLK3_HUMAN 0.993848117 -8.071944968 1.057569892 
OAT_HUMAN -9.929302799 2.734055165 1.000769209 
CDC5L_HUMAN 2.073375358 -9.907942177 0.960108676 
H2A1J_HUMAN 0.58130639 1.056951881 0.738216988 
ODB2_HUMAN 0.994496198 2.638771496 0.736795312 
TBA1A_HUMAN -7.574555686 2.466145001 0.735420807 
NOP56_HUMAN 0.991616276 0.469501869 0.734475527 
HS71L_HUMAN 0.991118205 0.469252722 0.734107857 
SSRP1_HUMAN 0.99505304 -1.522078189 0.544862646 
PPM1B_HUMAN 0.20003204 1.577484201 0.308705987 
U5S1_HUMAN 1.298784908 -2.846251758 0.290901674 
SP16H_HUMAN 1.315840207 -1.519385898 0.060224306 
CASC3_HUMAN 11.73089465 13.48645796 0 
WIBG_HUMAN 11.70852352 10.18512321 0 
CCDC9_HUMAN 9.914400082 0 0 
RL5_HUMAN 9.168697186 10.22809716 0 
REN3B_HUMAN 8.468705491 10.74852832 0 
BOLA2_HUMAN 0 12.01531051 0 
RL13_HUMAN 0 10.13647852 0 
RO52_HUMAN 0 9.551362204 0 
P53_HUMAN 0 9.24026662 0 
PRDX2_HUMAN 0 9.229299509 0 
GSHR_HUMAN 0 8.831528936 0 
C1TM_HUMAN 0 8.511475946 0 
TBB2A_HUMAN 0 8.063988217 0 
LAP2A_HUMAN 0 7.425845306 0 
EF1A1_HUMAN 
(+1) -0.22569663 1.249191701 -0.068927127 
TBB5_HUMAN -0.00348044 0.986567489 -0.161984954 
IRS4_HUMAN 0.986035447 2.776196272 -0.257407108 
DJC10_HUMAN -6.766065051 1.463811228 -0.258872981 
RS8_HUMAN 2.578589362 1.470068567 -0.26084481 
EFTU_HUMAN 0.410946763 1.692939326 -0.261061789 
STK38_HUMAN -0.003433705 1.056732389 -0.261408701 
REST_HUMAN -1.3198622 1.848156873 -0.581625339 
CK084_HUMAN -11.39580187 1.346444398 -0.676241922 
RL4_HUMAN 1.731826571 2.344806224 -0.844616109 
TBA4A_HUMAN -0.003471556 1.055272517 -1.256318815 
ILF2_HUMAN -8.779916297 1.055549917 -1.256981736 
SERA_HUMAN -0.225705018 0.986138055 -1.481694665 
CLAP2_HUMAN -0.58481771 2.051714144 -1.827854863 
HNRPL_HUMAN -8.770135276 1.470179053 -1.837979591 
E2F7_HUMAN -9.140190703 1.055919581 -1.839883907 
SERPH_HUMAN -7.683626283 1.467796235 -7.683626283 
HDAC6_HUMAN -0.584962501 1.689961089 -7.72900887 
AIFM1_HUMAN -8.129386063 1.054571811 -8.129386063 		
#Alternate EJC_replicate2 
175 proteins at 99% minimum, 2 minimum peptides, 0.0% decoy FDR;; 7282 spectra at 
95% minimum, 0.00% decoy FDR 
From proteins clusters, only member proteins with a non-zero value in at least one 
sample were retained  
Normalized spectral abundance factor (NSAF) values from Scaffold were used for 
quantitation; a psuedo count of 0.000001 was added to each NSAF value before 
determining enrichment in EJC IPs as compared to FLAG-only 
Proteins enriched >2-fold in any of the three EJC IPs over FLAG-only IP are shown 
    
 log2(NSAF) 
Accession Number Magoh MLN51 RNPS1 
IF4A3_HUMAN 13.7638348 11.03967305 13.42245903 
RNPS1_HUMAN 12.09199728 0 13.31783654 
MGN_HUMAN 14.55895875 10.9479291 12.93590168 
SMD1_HUMAN 11.36260139 0 12.86834029 
PININ_HUMAN 13.14623453 0 12.80982841 
H2A1D_HUMAN 
(+6) 12.04217235 0 12.74081375 
ACINU_HUMAN 12.39159267 0 12.71647653 
H4_HUMAN 0 0 12.5912652 
RU2A_HUMAN 10.8482317 12.3128546 12.48507456 
SRSF7_HUMAN 11.68439798 0 12.23101112 
SRSF1_HUMAN 11.30320995 0 12.08921873 
SAP18_HUMAN 11.32198445 0 12.02049387 
LC7L3_HUMAN 11.50248377 0 12.00842862 
RBM39_HUMAN 11.5997734 0 11.9935753 
SF3B1_HUMAN 11.7159191 11.37378957 11.79709406 
SMD3_HUMAN 0 0 11.78610623 
TRA2B_HUMAN 10.6727789 0 11.69300772 
U5S1_HUMAN 11.46183752 0 11.67511904 
RBM25_HUMAN 11.0617087 0 11.52214012 
PRP19_HUMAN 12.03479896 0 11.43827206 
RUXE_HUMAN 0 0 11.4325941 
SRRM1_HUMAN 11.72250872 0 11.38392025 
TR150_HUMAN 11.78418496 0 11.26631806 
SRRM2_HUMAN 11.4604559 0 11.23038076 
H13_HUMAN 0 12.51929225 11.16835873 
SRSF9_HUMAN 0 0 11.16835873 
LC7L2_HUMAN 10.64304445 0 11.1489214 
PR40A_HUMAN 10.74760559 0 11.14134082 
RSMB_HUMAN 
(+1) 9.352175878 11.55252501 11.04937211 
RU2B_HUMAN 0 11.32378662 10.94989965 
PRP4B_HUMAN 9.453003062 0 10.93472289 
SRSF3_HUMAN 10.48522554 0 10.92072502 
U520_HUMAN 9.841595796 0 10.89565101 
BCLF1_HUMAN 11.90358063 0 10.86581058 
SRSF6_HUMAN 9.832177982 0 10.70017959 
SMD2_HUMAN 0 0 10.65883628 
SNR40_HUMAN 10.7779128 0 10.64664871 
SF3B6_HUMAN 0 0 10.57572832 
H2B1C_HUMAN 
(+8) 0 10.16100588 10.56424478 
SF3A2_HUMAN 11.20683123 10.28019079 10.55803798 
U2AF2_HUMAN 9.688757349 0 10.52424786 
PPIG_HUMAN 9.700179593 0 10.39820926 
DDX41_HUMAN 10.78422586 0 10.37634248 
SNW1_HUMAN 10.89193556 0 10.35005518 
FIP1_HUMAN 0 0 10.32732808 
CDC5L_HUMAN 11.13359178 0 10.30924896 
PCBP1_HUMAN 9.782768932 0 10.28840471 
SRS10_HUMAN 10.54631572 0 10.24531501 
RS4X_HUMAN 10.21916852 0 10.23983717 
SCML1_HUMAN 0 0 10.17990909 
RBMX_HUMAN 10.45419646 0 10.15317199 
PRP8_HUMAN 8.771390425 0 10.12528431 
CH60_HUMAN 11.00204143 0 10.11647393 
RBM22_HUMAN 10.54361188 0 10.05012073 
XRCC6_HUMAN 0 0 9.876777836 
H33_HUMAN 0 0 9.86968637 
TRA2A_HUMAN 0 0 9.817655232 
RIOK1_HUMAN 10.27821712 10.79547151 9.807483728 
BUD31_HUMAN 0 0 9.787314917 
CCNK_HUMAN 9.66370041 0 9.777353958 
SON_HUMAN 9.968090752 0 9.757306662 
GRP75_HUMAN 10.5510353 0 9.71998768 
RS18_HUMAN 0 0 9.709411269 
AQR_HUMAN 9.307861087 0 9.669062209 
RL7_HUMAN 0 0 9.588246152 
RL7A_HUMAN 0 0 9.487297414 
XRCC5_HUMAN 0 0 9.441989675 
ISY1_HUMAN 9.688757349 0 9.387909618 
PGAM5_HUMAN 9.08459582 0 9.367829698 
RS2_HUMAN 9.064796646 10.52816105 9.348042047 
CSK21_HUMAN 0 0 9.3468018 
SNIP1_HUMAN 8.631140669 0 9.328495421 
SMU1_HUMAN 10.42500604 0 9.277054876 
SR140_HUMAN 9.421854445 10.59039992 9.272839701 
PR38A_HUMAN 0 0 9.257529276 
RLA0_HUMAN 9.535430915 8.831845581 9.234625857 
GPTC8_HUMAN 0 0 9.21273955 
SFR19_HUMAN 8.226074963 0 9.185494924 
SNUT1_HUMAN 7.620366471 0 9.121714814 
PAXB1_HUMAN 9.003855181 0 9.117435318 
H2A1A_HUMAN 
(+2) 0 0 8.925168681 
RL3_HUMAN 0 0 8.888986721 
HNRH1_HUMAN 9.034001065 0 8.733388238 
TBA1B_HUMAN 9.027601948 0 8.727001465 
PPIE_HUMAN 0 0 8.725400344 
HNRPC_HUMAN 10.00084508 10.4655664 8.701687664 
GRP78_HUMAN 9.490690457 0 8.6061831 
PLRG1_HUMAN 8.255972742 0 8.538848521 
RED_HUMAN 8.72369507 0 8.423241996 
CDK12_HUMAN 7.722602637 0 8.418738108 
PRP17_HUMAN 10.08081753 0 8.3675458 
DDX21_HUMAN 8.647602329 0 8.347178416 
RBBP6_HUMAN 7.04537744 0 8.322694323 
SPF45_HUMAN 10.61028666 10.07588021 8.312701473 
NKAP_HUMAN 0 0 8.263363107 
RL4_HUMAN 9.842271763 0 8.222360218 
SYF1_HUMAN 8.842161743 0 8.220668531 
SRRT_HUMAN 8.072427412 0 8.185767456 
MFAP1_HUMAN 0 0 8.182493675 
OAT_HUMAN 0 0 8.182493675 
CWC22_HUMAN 8.434503133 0 8.13422094 
EF1A1_HUMAN 
(+1) 8.409348503 0 8.109099329 
SRS11_HUMAN 0 0 8.04220656 
HNRPM_HUMAN 9.33230514 0 8.034358798 
DHX8_HUMAN 0 0 8.03039126 
ZC3HE_HUMAN 9.734997453 0 8.022589749 
SPTN1_HUMAN 8.574139362 6.877866923 8.011674533 
TAB1_HUMAN 8.867618521 9.162265434 7.984019633 
MATR3_HUMAN 0 0 7.820753373 
CRNL1_HUMAN 8.119096751 0 7.819029455 
CHERP_HUMAN 8.008204497 0 7.708256223 
CDK13_HUMAN 0 0 7.401903472 
MYH9_HUMAN 9.229515825 9.372473325 7.34978987 
TBB4B_HUMAN 9.046878442 8.343807528 7.168020189 
ZCH18_HUMAN 0 0 7.070067262 
NKTR_HUMAN 0 0 7.037821465 
IPO8_HUMAN 8.564416278 8.124017889 6.949184722 
CAMP3_HUMAN 0 0 6.683134985 
MAP1B_HUMAN 0 0 6.29000041 
SPTB2_HUMAN 6.649256178 0 5.775182264 
FLNA_HUMAN 7.218393711 0 5.615210284 
IF4B_HUMAN 2.319331128 3.873106719 1.625925187 
RBM8A_HUMAN 11.39943816 0 0 
CASC3_HUMAN 11.19241612 12.26488238 0 
CCDC9_HUMAN 10.20554891 0 0 
COR1C_HUMAN 9.691795853 10.24946904 0 
REN3B_HUMAN 9.664678382 0 0 
PYM1_HUMAN 9.586314394 0 0 
HNRPK_HUMAN 8.989791843 0 0 
HNRPR_HUMAN 8.953701754 0 0 
SRSF4_HUMAN 8.896483781 0 0 
SLU7_HUMAN 8.65065687 0 0 
FL2D_HUMAN 8.631140669 0 0 
HNRPF_HUMAN 8.563692024 0 0 
OTUD4_HUMAN 7.727103604 0 0 
LIMA1_HUMAN 7.695854658 8.572851782 0 
TBA1C_HUMAN 7.454504938 0 0 
K2C8_HUMAN 7.349878311 0 0 
TMOD3_HUMAN 0 11.26315181 0 
PRDX1_HUMAN 0 11.0860035 0 
 
Table S2. Summary of all described RIPiT-Seq and RNA-Seq libraries. 
 
*All numbers represent unique counts 
**Tables A-D show counts in sequential order of processing 
Table A. Multi-mapping and PCR duplicate read removal 
Library 
TopHat 
Input 
Total Mapped (%) 
Multi-
Mapped (%) 
Input 
Reads 
Multi-
Mapper
s (%) 
PCR 
Duplicate
s (%) 
MAGOH-EIF4A3 12289132 11788001 95.92 919103 7.8 11788001 919103 7.8 38395 0.33 
CASC3-EIF4A3 7918724 7552965 95.38 501748 6.64 7552965 501748 6.64 14235 0.19 
RNPS1-EIF4A3 9353236 8964991 95.85 921854 10.28 8964991 921854 10.28 16528 0.18 
MAGOH-CASC3 6792045 6423758 94.58 408153 6.35 6423758 408153 6.35 31314 0.49 
MAGOH-RNPS1 11996168 11169040 93.11 617910 5.53 11169040 617910 5.53 35527 0.32 
CASC3-EIF4A3-XL-A 5718072 5309270 92.85 370143 6.97 5309270 370143 6.97 10068 0.19 
CASC3-EIF4A3-XL-B 21898851 20055735 91.58 3554071 17.72 20055735 3554071 17.72 2013494 10.04 
RNPS1-EIF4A3-XL-A 8370005 7838852 93.65 651639 8.31 7838852 651639 8.31 23133 0.3 
RNPS1-EIF4A3-XL-B 24859586 23434622 94.27 4666719 19.91 23434622 4666719 19.91 715018 3.05 
CASC3-EIF4A3-XL-A (+CHX) 15795694 15084794 95.5 684318 4.54 15084794 684318 4.54 182916 1.21 
CASC3-EIF4A3-XL-B (+CHX) 13937900 13413713 96.24 523380 3.9 13413713 523380 3.9 75455 0.56 
RNPS1-EIF4A3-XL-A (+CHX) 27687914 26580410 96 2258708 8.5 26580410 2258708 8.5 187891 0.71 
RNPS1-EIF4A3-XL-B (+CHX) 2532100 2274851 89.84 95329 4.19 2274851 95329 4.19 26077 1.15 
RNA-Seq-A 18740947 12180518 64.99 4873419 40.01 12180518 4873419 40.01 58947 0.48 
RNA-Seq-B 19476485 12592943 64.66 4811993 38.21 12592943 4811993 38.21 46021 0.37 
 
Table B. Removal of miscellaneous RNAs 
Library 
Mitocho
ndrial (%) 
miRN
A (%) (%) 
rRNA 
(+ChrUn) (%) 
scaRN
A (%) 
snoRN
A (%) snRNA (%) tRNA (%) 
Final 
Count 
MAGOH-EIF4A3 144700 1.23 1384 0.01 0 3524726 29.9 396 0 20182 0.17 677876 5.75 2223 0.02 6459016 
CASC3-EIF4A3 124075 1.64 787 0.01 0 4946036 65.48 102 0 4582 0.06 462939 6.13 3095 0.04 1495366 
RNPS1-EIF4A3 108423 1.21 879 0.01 0 3215430 35.87 193 0 7039 0.08 1275182 14.22 3955 0.04 3415508 
MAGOH-CASC3 35630 0.55 936 0.01 0 3663566 57.03 105 0 3038 0.05 163479 2.54 4305 0.07 2113232 
MAGOH-RNPS1 60106 0.54 1511 0.01 0 5766613 51.63 133 0 4938 0.04 385709 3.45 4516 0.04 4292077 
CASC3-EIF4A3-XL-A 22902 0.43 1264 0.02 0 3382695 63.71 322 0.01 7479 0.14 140262 2.64 3892 0.07 1370243 
CASC3-EIF4A3-XL-B 98373 0.49 3261 0.02 0 11708237 58.38 1866 0.01 6384 0.03 1297149 6.47 10183 0.05 1362717 
RNPS1-EIF4A3-XL-A 28638 0.37 1455 0.02 0 3253080 41.5 896 0.01 16125 0.21 506409 6.46 4484 0.06 3352993 
RNPS1-EIF4A3-XL-B 50751 0.22 6254 0.03 0 9460234 40.37 3923 0.02 13060 0.06 2295813 9.8 8177 0.03 6214673 
CASC3-EIF4A3-XL-A (+CHX) 47903 0.32 14652 0.1 0 4289703 28.44 334 0 7472 0.05 76118 0.5 8924 0.06 9772454 
CASC3-EIF4A3-XL-B (+CHX) 60192 0.45 6725 0.05 0 4702167 35.05 243 0 4686 0.03 71546 0.53 6357 0.05 7962962 
RNPS1-EIF4A3-XL-A (+CHX) 132946 0.5 2653 0.01 0 12002630 45.16 1679 0.01 36309 0.14 1267031 4.77 21014 0.08 10669549 
RNPS1-EIF4A3-XL-B (+CHX) 3478 0.15 110 0 0 1526002 67.08 49 0 235 0.01 9165 0.4 93 0 614313 
RNA-Seq-A 507860 4.17 11319 0.09 0 693781 5.7 5463 0.04 183690 1.51 481999 3.96 1883466 15.46 3480574 
RNA-Seq-B 535924 4.26 13299 0.11 0 506876 4.03 6870 0.05 298611 2.37 673413 5.35 1945855 15.45 3754081 
 
  
Table C. Genomic read distribution (51% overlap) 
Library Exonic (%) RPKM Intronic (%) RPKM Intergenic (%) 
1 Exon 
Genes RPKM 
2+ Exon 
Genes RPKM 
MAGOH-EIF4A3 4384496.00 67.88 7.40 1797361.00 27.83 0.19 277159.00 4.29 30122.00 1.70 4473662.00 7.78 
CASC3-EIF4A3 906277.00 60.61 6.61 504613.00 33.75 0.23 84476.00 5.65 11554.00 2.82 924113.00 6.94 
RNPS1-EIF4A3 2162371.00 63.31 6.90 1098461.00 32.16 0.22 154676.00 4.53 23011.00 2.46 2209957.00 7.27 
MAGOH-CASC3 1476411.00 69.87 7.61 531464.00 25.15 0.17 105357.00 4.99 15495.00 2.68 1505597.00 8.00 
MAGOH-RNPS1 3046675.00 70.98 7.74 1026440.00 23.91 0.16 218962.00 5.10 30176.00 2.57 3105684.00 8.13 
CASC3-EIF4A3-XL-A 914747.00 66.76 7.28 379830.00 27.72 0.19 75666.00 5.52 7480.00 1.99 936445.00 7.68 
CASC3-EIF4A3-XL-B 1193285.00 87.57 9.54 692445.00 50.81 0.34 523013.00 38.38 16125.00 4.32 1231702.00 10.15 
RNPS1-EIF4A3-XL-A 2274827.00 67.84 7.39 908998.00 27.11 0.18 169168.00 5.05 15559.00 1.70 2336427.00 7.83 
RNPS1-EIF4A3-XL-B 7357943.00 118.40 12.90 3281206.00 52.80 0.36 4424476.00 71.19 53784.00 3.16 7573547.00 13.69 
CASC3-EIF4A3-XL-A 
(+CHX) 7860415.00 80.43 8.77 1741791.00 17.82 0.12 170248.00 1.74 47235.00 1.77 8010464.00 9.21 
CASC3-EIF4A3-XL-B 
(+CHX) 6528217.00 81.98 8.94 1331364.00 16.72 0.11 103381.00 1.30 26773.00 1.23 6674856.00 9.42 
RNPS1-EIF4A3-XL-A 
(+CHX) 7057878.00 66.15 7.21 3096590.00 29.02 0.20 515081.00 4.83 46214.00 1.58 7205508.00 7.59 
RNPS1-EIF4A3-XL-B 
(+CHX) 454507.00 73.99 8.06 117397.00 19.11 0.13 42409.00 6.90 4588.00 2.73 463153.00 8.47 
RNA-Seq-A 1059522.00 30.44 3.32 1761478.00 50.61 0.34 659574.00 18.95 81172.00 8.52 1064409.00 3.44 
RNA-Seq-B 1080657.00 28.79 3.14 1785669.00 47.57 0.32 887755.00 23.65 110593.00 10.76 1072926.00 3.21 
 
 
 
Table D. Canonical/Non-canonical read classification 
Library Canonical (%ofExonic) Non-Canonical (%ofExonic) Uncounted (%ofExonic) 
MAGOH-EIF4A3 1546096.00 35.26 2722620.00 62.10 115780.00 2.64 
CASC3-EIF4A3 289135.00 31.90 579485.00 63.94 37657.00 4.16 
RNPS1-EIF4A3 811486.00 37.53 1267130.00 58.60 83755.00 3.87 
MAGOH-CASC3 476638.00 32.28 951547.00 64.45 48226.00 3.27 
MAGOH-RNPS1 898705.00 29.50 2006039.00 65.84 141931.00 4.66 
CASC3-EIF4A3-XL-A 326669.00 35.71 530307.00 57.97 57771.00 6.32 
CASC3-EIF4A3-XL-B 587174.00 49.21 543975.00 45.59 62136.00 5.21 
RNPS1-EIF4A3-XL-A 723741.00 31.82 1407464.00 61.87 143622.00 6.31 
RNPS1-EIF4A3-XL-B 2555021.00 34.72 4178245.00 56.79 624677.00 8.49 
CASC3-EIF4A3-XL-A 
(+CHX) 2386087.00 30.36 4692151.00 59.69 782177.00 9.95 
CASC3-EIF4A3-XL-B 
(+CHX) 3145982.00 48.19 2672452.00 40.94 709783.00 10.87 
RNPS1-EIF4A3-XL-A 
(+CHX) 1593969.00 22.58 4853509.00 68.77 610400.00 8.65 
RNPS1-EIF4A3-XL-B 
(+CHX) 46447.00 10.22 358889.00 78.96 49171.00 10.82 
 
Table S3. List of reagents (siRNA sequences, qRT-PCR primers, antibodies, 
plasmids) 
 
siRNAs 
Gene siRNA sequence Reference 
AllStars Negative Control 	 Qiagen proprietary sequence  
EIF4A3_187	 CGA GCA AUC AAG CAG AUC AUU	 This Study 
CASC3_534	 CCA GCA UAC AUA CCU CGG AUU	 This Study 
RNPS1_2	 GCA UCC AGC CGC UCA GGA AUU	 This Study 
 
 
qRT-PCR primers 
Gene Primer (Forward) Primer (Reverse) Reference 
GADD45A GAGCTCCTGCTCTTGGAGAC GCAGGATCCTTCCATTGAGA This Study 
UPP1 CCAGCCTTGTTTGGAGATGT ACATGGCATAGCGGTCAGTT This Study 
ARC CTGAGATGCTGGAGCACGTA GCCTTGATGGACTTCTTCCA This Study 
DNAJB2 TGGCATCCTACTACGAGATCC GTTTTTGTCTGGGTGCCACT This Study 
eIF4A2 TGTGGAGACGGTGACAGATTC TTCCTGCTTTACCCACCAGTAC This Study 
TMEM33 AGGGTCAAGTCGTGTTCTGATC ACCAACTGCTGCTATCGACTC This Study 
SF3B1 CACGGCAATGTGGCTTTCTC ACTCACCAAGAAGAGGCAGAAC This Study 
CAPN7 AATTTCCCCAGAGCGTCTTG TTCGTGCCTTTGTCTCCATC This Study 
TPT1 CAACGGGAAGGCGAGCTCTC GGAAGGAGCGGCAAAGTTTAC This Study 
C1orf37 TCATCAGCCATGGTCAGTAGG TGCAGGTGATGGTTCATGAC This Study 
SRSF2 TTGCTGCTCGAATCTCCAAG ACTTCTGCTGCCATCACAAC Lareau et al., 2007 
SRSF4 CCTCTTAAGAAAATGCTGCGGTCTC ATCAGCCAAATCAGTTAAAATCTGC Lareau et al., 2007 
SRSF6 GGATCTGAAGAACGGTCTGTTATGT TCACTCGTCTTTTGGTTCCCATTAG Lareau et al., 2007 
RPL3 TGGTGGAAAAGGTCCTTAG TCAGGAGCAGAGCAGAGTTG This Study 
RPL12 CTGGGCCTTAGCTTCTTCAC AAGTGGCACCGACTTCACCT This Study 
ACTB CGCGAGAAGATGACCCAGAT TCACCGGAGTCCATCACGAT This Study 
 
 
Antibodies 
Protein Source Catalog# 
CASC3 Bethyl Laboratories A302-472  
RNPS1 Sigma Aldrich HPA044014 
RNPS1  Akila Mayeda  
EIF4A3 Bethyl Laboratories A302-980A 
HNRNPA1 Santa Cruz Biotechnology SC-32301 
ACIN1 Bethyl Laboratories A300-999A 
SAP18 Santa Cruz Biotechnology SC-25377 
RBM8A Sigma Aldrich Y1253 (4C4) 
MAGOH Santa Cruz Biotechnology SC-271365 
SRSF1 Santa Cruz Biotechnology SC-33652 
FLAG Sigma Aldrich F1804 
 
 
 
 
 
Reagents 
Reagent Source Catalog# 
Protein A Dynabeads Life Technologies 10002D 
Protein G Dynabeads Life Technologies 10003D 
FLAG-Agarose Beads Sigma Aldrich A2220 
FLAG peptide Sigma Aldrich F3290 
MWCO 7,000 Da Dialysis Column Pierce 88242 
4X Lammelli SDS load buffer Bio-Rad 161-0737 
4%–15% Mini-PROTEAN TGX Bio-Rad 4561086 
Trypsin Gold Promega V5280 
ProteaseMAXTM Surfactant Promega V2071 
TransIT-X2 Mirus MIR 6003 
RNAiMAX Thermo Fisher 13778030 
JetPrime PolyPlus 114-01 
oligo-(dT)15 Primer Promega C1101 
Superscript III Invitrogen 18080044 
Ribonuclease H Promega M4281 
2X SYBR Green Master Mix Applied Biosystems 4309155 
RNase I Promega M4261 
Ribo-Zero rRNA Removal Kit (H/M/R) Illumina MRZH116 
 
Plasmids 
Plasmid Reference 
pcβwtβ Lykke-Andersen, 2000 
pcβ39β Lykke-Andersen, 2000 
pcTET2-βwtβ Singh et al., 2007 
pcTET2-β39β Singh et al., 2007 
pcβwtGAP3UAC Lykke-Andersen, 2000 
pcDNA3  Singh et al., 2012 
pcDNA3 YFP This study 
pcDNA3 FLAG Singh et al., 2012 
pcDNA3 FLAG-EIF4AIII Singh et al., 2012 
pcDNA3 FLAG-EIF4AIII YRAA This study 
pcDNA3 FLAG-MAGOH Singh et al., 2012 
pcDNA3 FLAG-RNPS1 This study 
pcDNA3 FLAG-CASC3 This study 
pcDNA3 FLAG-HNRNPA1 This study 
pcDNA5 FLAG-MAGOH Singh et al., 2012 
pcDNA5 FLAG-RNPS1 This study 
pcDNA5 FLAG-CASC3 This study 
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EXPERIMENTAL PROCEDURES 
Plasmids, Cell lines and cell culture 
Plasmids expressing EJC factors and hnRNPA1 were generated by cloning their cDNAs 
into derivatives of pcDNA3.1 (for transient expression) or pcDNA5-FLAG-FRT/TO (for 
stable expression) as described previously (Singh et al., 2012). Plasmids expressing β-
globin reporters have been described elsewhere (Lykke-Andersen, 2000; Singh, 2007). 
Human cell lines (HEK293 Flp-In TRex, HeLa CCL2, HeLa Tet-off)  were cultured in 
Dulbecco’s modified eagle medium (DMEM) supplemented with 10 % fetal bovine 
serum (FBS) and 1 % penicillin-streptomycin. Stable cell lines expressing tetracycline-
inducible FLAG-tagged proteins were created using HEK293 Flp-In TRex cells as 
described previously (Singh et al., 2012). 
 
Endogenous Immunoprecipitations 
HEK293, HeLa and P19 cells were lysed and sonicated in hypotonic lysis buffer (HLB) 
[20 mM Tris-HCl pH 7.5, 15 mM NaCl, 10 mM EDTA, 0.5 % NP-40, 0.1 % Triton X-100, 
1 x Sigma protease inhibitor cocktail, 1 mM PMSF]. Lysates were sonicated, increased 
to 150 mM NaCl and treated with RNase A for five minutes. Complexes were then 
captured on Protein A/G Dynabeads (Life Technologies) conjugated to IgG, α-EIF4A3, 
α-CASC3 or α-RNPS1 antibodies for 2 hr nutating at 4 °C. Complexes were washed in 
isotonic wash buffer (IsoWB) [20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1 % NP-40] and 
eluted in clear sample buffer [100 mM Tris-HCl pH 6.8, 4 % SDS, 10 mM EDTA, 100 
mM DTT]. Cortical neurons were isolated from FBV wild-type male mice in HBSS buffer. 
Once isolated, lysate preparation was carried out as stated above.  
 
FLAG Immunoprecipitations 
Stable HEK293 cells expressing FLAG-tagged EJC protein were lysed in HLB. Lysates 
were sonicated, increased to 150 mM NaCl and treated with RNase A. Complexes were 
then captured on FLAG-beads, washed with IsoWB and FLAG-peptide eluted. IPs were 
carried out as noted above. 
 
Mass Spectrometry 
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FLAG Immunoprecipitation 
Stably expressed FLAG-MAGOH, FLAG-CASC3, FLAG-RNPS1, or FLAG-peptide were 
IPed and RNase A digested at 4 °C for 2 hr in lysis buffer supplemented with 1 µg/ml 
FLAG peptide to improve IP specificity. The FLAG affinity elution was completely dried 
by vacuum evaporation, re-suspended in 100 µl of water and dialyzed (dialysis buffer: 
10 mM Tris-HCl pH7.5, 75 mM NaCl, 0.01 % Triton X-100) for ~6 hr at 4 °C in a MWCO 
7,000 Da mini dialysis column (Pierce). The dialyzed sample (90-100 µl) was again 
completely dried by vacuum evaporation and re-suspended in 20 µl of 0.1 % SDS and 
10 mM DTT (prepared from a fresh stock solution). The sample was heated at 95 °C for 
5 min and cooled to room temperature. The reduced thiol groups were alkylated by 
incubating with 0.8 µl of freshly prepared 1M iodoacetamide at room temperature for 45 
min in dark. The resulting samples were mixed with 5 µl of 4 x Lammelli SDS load buffer 
(Bio-Rad) and loaded on 4 %–15 % Mini-PROTEAN TGX gel (Bio-Rad). The samples 
were migrated until the dye-front had run approximately 1 cm into the gel from the 
bottom of well. The gel was washed three times with ~200 ml HPLC grade water for 5 
min each. The gel piece containing protein was excised and processed for in gel 
digestion of proteins.   
 
In-Gel Digestion  
The gel slices were cut into 1×5×1mm3 dimension and transferred into a 1.5 mL 
microcentrifuge tube. Samples were washed with water and dehydrated in acetonitrile 
:50 mM NH4HCO3 (1:1 v/v) for 5 minutes and 100% acetonitrile for 30 seconds. 
Following drying with a vacuum concentrator (Savant), gel slices were rehydrated in 25 
mM dithiothreitol in 50 mM NH4HCO3 and incubated for 20 min at 56 °C. With the 
removal of the supernatant, 55 mM iodoacetamide in 50 mM NH4HCO3 was added and 
the samples were incubated in the dark for 20 min at room temperature. Gel slices were 
washed and dehydrated as described before. Following removal of the liquid by vacuum 
concentrator, the sample was rehydrated in 12 ng/µL Trypsin Gold (Promega) in 0.01 % 
ProteaseMAXTM Surfactant (Promega): 50 mM NH4HCO3 and incubated at 50 °C for 
one hr. Condensate was collected by centrifuging at 14,000 × g for 10 seconds and the 
solution was transferred to a new tube. Trifluoroacetic acid was added to a final 
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concentration of 0.5 % to inactivate trypsin and the solution was dried by vacuum 
concentrator. 
 
LC/MS/MS 
The LC-MS/MS tryptic digested peptides were dissolved in 0.1 % formic acid (v/v) and 
loaded at 15 µL/min for 10 min using a nanoACQUITY C18 Trap column (20×0.18 mm 
i.d., 5 µm 100Å C18, Waters, 186007238). Peptides were separated using an EASY-
Spray LC Column(150×0.075 mm i.d., 3 µm 100Å C18, ThermoFisher, ES800) with a 
gradient using solvent A (0.1 % formic acid in water) and solvent B (0.1 % formic acid in 
acetonitrile) at a 0.5 µL/min flow rate. The gradient started with 1 % B for 5 min, 
followed by 85 min with a linear increase to 35 % B. The gradient was increased to 85 
% B in 5 min followed by decreasing back to 1 % B in 5 min as the final wash step. A  
nanoACQUITY UPLC (Waters) was coupled to a Velos Pro Dual-Pressure Linear Ion 
Trap mass spectrometer (Thermo Scientific) for data acquisition. A data-dependent 
acquisition routine was used for a mass spectrum from m/z 300 to 2000 and followed by 
ten tandem mass spectrometry scans. 
 
Data Analysis 
Raw data files were processed using Proteome Discoverer (ThermoFisher). The data 
were searched against the human Swiss-Port index (09/01/15) using Sequest HT with 
precursor mass tolerances of 1.5 Da and fragment mass tolerances of 0.8 Da. 
Maximum missed cleavage sites of full tryptic digestion was two and dynamic 
modifications of acetylation (N-terminus), carbamidomethylation(cysteine), 
propionamidation(cysteine) and oxidation(methionine) were considered. The processed 
mass spectrometry data was analyzed using the Scaffold software (4.4.5). 
Quantifications from replicate 1 are presented in main figures and from replicate 2 in 
supplementary figures. For the analysis presented in Figure 1 and S1, spectral 
quantification was done using the normalized weighted spectral counts with minimum 
peptide identification threshold at 95 % and protein identification threshold of 95 % with 
1 minimum peptide. For analysis presented in Figure 2 and S2, spectral quantification 
was done using the Normalized Spectral Abundance Factor (NSAF) (Zhang et al., 
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2010). A total of 341 (replicate 1) or 259 (replicate 2) proteins were identified at 99 % 
threshold each with a minimum of 2 peptides. When Scaffold grouped together similar 
proteins into clusters, only those proteins were retained from a cluster that had non-zero 
NSAF value in at least one of the four samples. There are several proteins that are 
detected only in one or the other alternate EJC, and thus had zero values in samples 
where they were undetected. Also, many EJC specific proteins had zero values in 
FLAG-only control IPs. A pseudocount of 0.00001 was added to all NSAF values to 
prevent loss of such proteins when divided by zero. Fold-enrichment over FLAG-only 
control was calculated for each of the three EJC samples as follows: 
 
Fold-enrichment:  
log2[NSAF(FLAG-EJC+0.00001)] / [NSAF(FLAG-only+0.000001)]    
 
The comparison of fold-enrichment values for all 341 proteins in the EJC core or 
alternate EJCs was carried out in R package ggplot2 (via scatter plots). Proteins that 
were >10-fold enriched in one of the three EJC IPs were included in the heatmap (using 
R package gplots). In this analysis, proteins that most likely were contaminants (e.g. 
cytoskeleton proteins, histones, metabolic enzymes) were not included in the heatmap 
but are shown in the >10-fold enrichment table.  
  
 
Glycerol Gradient Fractionation 
Five 15-cm plates with ~90 % confluent HEK293 cells expressing FLAG-tagged 
MAGOH, CASC3, RNPS1 proteins, or FLAG-peptide as a control, were cultured and 
induced as above. Cell lysis, FLAG-immunoprecipitation, RNase A digestion and FLAG-
elution steps were also carried out as described above. FLAG-IP elution was layered 
onto pre-cooled continuous 10-30 % glycerol gradients prepared in 11 ml Beckman 
centrifuge tubes. Gradients were run at 32,000 rpm for 16 hours at 4 °C. Gradients were 
fractionated by-hand into 500 µl fractions. Proteins were precipitated using TCA and 
resuspended in 15 µl of 1x SDS loading buffer for analysis on 12 % SDS-PAGEs.  
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siRNA-mediated Knockdowns 
HEK293 siRNA knockdowns 
HEK293 cells were seeded into 24-well plates. Cells were transfected 4 hours later 
following the Mirus TransIT-X2 procedure with 55-60 pmols of control, EIF4A3, CASC3, 
RNPS1, or UPF1 siRNA. Cells were harvested 48 hr later. Knockdown was checked by 
Western blot and subsequently purified RNA was used for qRT-PCR analysis. For 96 hr 
knockdowns, HEK293 cells were transfected as above and were incubated for 24 hr. 
Cells were transfected again at roughly 70-80 % confluence following the Mirus 
TransIT-X2 procedure using 50-60 pmol of control, EIF4A3, CASC3, RNPS1, or UPF1 
siRNA. Cells were harvested ~48 hr (~96 total hours after first transfection) later. 
Knockdown was checked by Western blot and subsequently purified RNA was used for 
qRT-PCR analysis. 
 
HeLa Tet-off siRNA knockdowns and reporter RNA expression 
HeLa Tet-off cells in 12-well plates (1.2 x 105 cells/well) were reverse transfected with 
15 pmol of control, UPF1, CASC3 and RNPS1 siRNA using RNAiMAX following the 
manufacturer’s protocol. After 24 hr, cells were co-transfected with plasmids (100 ng of 
pcTET2-βwtβ or pcTET2-β39β, 30 ng of pcβwtGAP3UAC and 70 ng of pezYFP or 
carrier DNA) and a second dose of 15 pmol of siRNA using JetPrime (PolyPlus).  
Tetracycline (50 ng/ml) was included at the time of transfection to repress reporter RNA 
expression, and was removed 20 hr later to induce reporter RNA expression for 6-8 hr. 
Cells were harvested in clear sample buffer for western blot analysis and TRIzol 
extraction of RNA, which was analyzed by Northern Blotting. 
 
Overexpression of alternate EJC factors 
HEK293 FLAG-EJC overexpression  
HEK293 cells expressing FLAG-tagged CASC3, RNPS1 proteins, or FLAG-peptide as a 
control, were seeded into 6-well plates. Cells were induced with 625 ng/ml of 
Doxycycline for 48 hr. Overexpression was checked by Western blot and subsequently 
purified RNA was used for qRT-PCR analysis. 
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For IPs following alternate EJC protein overexpression, HEK293 cells stably 
expressing FLAG-tagged CASC3 or RNPS1, or FLAG-peptide as a control, were 
seeded in 10 cm plates and induced with 625 ng/ml of Doxycycline for 48 hr. 
Endogenous RBM8A or EIF4A3 IPs were carried out as described above. 
 
HEK293 EIF4A3 or EIF4A3 YRAA Rescue 
HEK293 cells were seeded into 24-well plates. Cells were transfected 4 hr later 
following the Mirus TransIT-X2 procedure with 60 pmol of control, or EIF4A3 siRNA, 
and 300 ng of pcDNA3 empty, FLAG-EIF4A3 wt or FLAG-EIF4A3 YRAA and 200 ng of 
pcDNA3 vector. Cells were harvested ~48 hr later. Knockdown and EIF4AIII expression 
was checked by Western blot and subsequently purified RNA was used for qRT-PCR 
analysis. 
 HEK293 cells were seeded into 6-well plates. Cells were transfected four hours 
later following the Mirus TransIT-X2 protocol with 300 ng of pcDNA3 empty, FLAG-
EIF4A3 wt or FLAG-EIF4A3 YRAA and 200 ng of pcDNA3 vector. Cells were harvested 
in 1x PBS 48 hr later and washed for subsequent FLAG IP as previously described.  
 
β-globin NMD assays 
The pulse-chase experiments were performed in HeLa Tet-off cells as described 
previously (Singh et al., 2007). Briefly, cells growing in 12-well plates were transfected 
with 10 ng of pcβwtGAP3UAC, 200 ng of pcTET2-β39β and 250 ng of pezFLAG-
CASC3 (or pezFLAG empty vector) in the presence of 50 ng/nl tetracycline. 36 hr later, 
expression of β39 mRNA was induced for 6 hr by removing Tet, and then supressed 
again via addition of 1 µg/ml Tet. Time points were collected starting ~30 min after 
addition of Tet for 0 hr time point. Total RNA was extracted using TRIzol and one-half of 
the RNA sample was analyzed by Northern blots. The autoradiogram signal was 
scanned using Fuji FLA imager, and quantified using ImageQuant software. 
For steady-state assays, HeLa CCL2 cells growing in 12-well plates were 
transfected with 100 ng of pcβwtGAP3UAC, 100 ng of either pcβwtβ or pcβ39β, and 
150 ng of pezFLAG plasmids (expressing RNPS1 or CASC3, or empty vector as a 
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control). Cells were harvested 48 hr post-transfections and total RNA extracted was 
analyzed by Northern blots.     
 
qRT-PCR 
RNA was isolated from cells using Trizol, DNase treated, purified with 
Phenol:Chloroform:Isoamyl alcohol (25:24:1, pH 4.5) and resuspended in RNase-free 
water. RNA was reverse transcribed using oligo-dT (Promega) and Superscript III 
(Invitrogen). After reverse transcription of RNA the samples were treated with RNase H 
(Promega) for 30 min at 37 °C. The samples were then diluted to 5 ng/µl before 
proceeding to qPCR setup. For each qPCR 25 ng of cDNA was mixed with 7.5 µl of 2 x 
SYBR Green Master Mix (ABS), 0.6 µl of a 10 mM forward and reverse primer mix 
(defrosted once), and quantity sufficient water for a 15 µl reaction volume. The qPCRs 
were performed on (Applied Biosystems) in triplicates (technical). Parallel with NMD 
targets, β-actin or TATA-binding protein (TBP) were used as internal controls. Fold-
change calculations were performed by delta-delta Ct method. Fold-change from at 
least three biological replicates were used to determine the standard error of means. 
The p-values were calculated using student’s t-test.    
 
Cytoplasmic FLAG-IPs of alternate EJCs 
One 15-cm plate of HEK293 cells expressing FLAG-tagged MAGOH, CASC3, RNPS1 
proteins, or FLAG-peptide as a control, were cultured and induced as above. Cells were 
lysed in 2 ml RSB-150 buffer [10 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM MgCl2, 10 
µg/ml Aprotinin, 10 µM Leupeptin, 1 µM Pepstatin, 1 mM PMSF] supplemented with 
0.05 % digitonin and 1 mM DTT. Lysates were passed through a 25 gauge needle 5 
times before centrifugation at 3,000 x g for 1 min at 4 °C. Supernatant was removed and 
centrifuged at 21,000 x g for 10 min at 4 °C, and passed through a 0.45 µm filter 
(Cytoplasmic Fraction). The first pellet was resuspended in RSB-150 and pelleted again 
at 3,000 x g for 1 min at 4 °C to remove residual cytoplasmic contaminants. The nuclei 
were then resuspended in 2 ml RSBT (components) and sonicated as previously 
described, before being centrifuged and purified as done for the cytoplasmic fraction. 
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Approximately 2 ml of each fraction were collected and used for FLAG-IP as described 
above. 
 
 
RIPiT-Seq data analysis 
 
Alternate EJC RIPiTs from HEK293 cells  
RIPiTs were carried out with and without formaldehyde crosslinking as described 
previously (Singh et al., 2014) with the following modifications. For native RIPiTs, total 
extracts from four 15-cm plates prepared in hypotonic lysis buffer supplemented with 
150mM NaCl-containing were used as input into FLAG-IP. For formaldehyde 
crosslinked RIPiTs, total extracts were prepared from six 15-cm plates in denaturing 
lysis buffer supplemented with 150 mM NaCl-containing for input into FLAG-IP. 
Following IP and washes, RNase I (0.006 U/ml in Isotonic wash buffer (IsoWB)) 
treatments were performed at 4 °C for 10 min. For the second IP, the following 
antibodies conjugated to protein-A Dynabeads were used: anti-EIF4A3 (Bethyl A302-
980A, 10 µg/RIPiT), anti-CASC3 (Bethyl A302-472A, 2 µg/RIPiT), anti-RNPS1 
(HPA044014-100UL, 2 µg/RIPiT). RIPiTs were eluted in clear sample buffer and divided 
into two parts for RNA and protein analysis as described previously. RIPiTs to enrich 
EJC footprints upon cycloheximide (CHX) treatment were carried out as above except 
that cells were incubated with 100 µg/ml CHX for 3 hr prior to harvesting. CHX was 
included at the same concentration in PBS (for washes before lysis) and cell lysis 
buffers. 
 
High-throughput sequencing library preparation 
For RIPiT-Seq, RNA extracted from ~80 % of RIPiT elution was used to generate 
strand-specific libraries using a custom library preparation method as detailed in 
(Gangras et al., 2018). For RNA-Seq libraries, 5 µg of total cellular RNA  was used as 
input for ribosomal RNA depletion (Ribozero, Illumina).  Purified RNA was then used to 
generate strand-specific libraries using a custom library preparation method (Gangras et 
al., 2018). Following PCR amplification, all libraries were quantified using Bioanalyzer 
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(DNA lengths) and Qubit (DNA amounts). Libraries were sequenced on Illumina HiSeq 
2500 in the single-end format (50 and 100 nt read lengths). 
 
Data pre-processing  
Adapter trimming and PCR duplicate removal 
After demultiplexing, fastq files containing unmapped reads were first trimmed using 
cutadapt. A 12 nt sequence on read 5’ ends consisting of a 5 nt random sequence, 5 nt 
identifying barcode, and a CC was removed with the random sequence saved for each 
read for identifying PCR duplicates down the line. Next as much of the 3’-adapter (miR-
Cat22) sequence TGGAATTCTCGGGTGCCAAGG was removed from the 3’ end as 
possible. Any reads less than 20 nt in length after trimming were discarded. 
 
Alignment and removal of multimapping reads 
Following trimming reads were aligned with tophat v2.1.1 (Trapnell et al., 2009) using 
12 threads to NCBI GRCh38 with corresponding Bowtie2 index. After alignment reads 
with a mapping score less than 50 (uniquely mapped) were removed, i.e. all 
multimapped reads were discarded. Finally all reads mapping to identical regions were 
compared for their random barcode sequence; if the random sequences matched, such 
reads were inferred as PCR duplicates and only one such read was kept. 
 
Removal of stable RNA mapping reads 
Next, reads which came from stable RNA types were counted and removed as follows. 
All reads were checked for overlap against hg38 annotations for miRNA, rRNA, tRNA, 
scaRNA, snoRNA, and snRNA using bedtools intersect (Quinlan and Hall, 2010), and 
any reads overlapping by more than 50 % were removed. Reads aligned to chrM 
(mitochondrial) were also counted and removed. 
 
Human reference transcriptome  
The primary reference transcriptome used in all post-alignment analysis was obtained 
from the UCSC Table Browser. CDS, exon, and intron boundaries were obtained for 
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canonical genes by selecting Track: Gencode v24, Table: knownGene, Filter: 
knownCanonical (describes the canonical splice variant of a gene). 
 
Read distribution assignment 
Fractions of reads corresponding to exonic, intronic, intergenic, and canonical EJC and 
non-canonical EJC regions were then computed. Exonic regions were defined by the 
canonical hg38 genes, with intronic regions defined as the regions between exons in 
said genes. Bedtools intersect was used to compare reads against these exon and 
intron annotations, and reads which overlapped the annotation by more than 50 % were 
counted. Any reads which did not overlap either the exon or intron annotations 
sufficiently were counted as intergenic. For classification of reads as canonical versus 
non-canonical EJC footprints, the canonical region for each library was defined using 
the meta-exon distribution at exon 3’-ends (Figure 3C and S3J). All reads with their 
5’ends  falling within the window starting at -24 position till the 25 % max height on the 
5’ side of the canonical EJC peak were counted as canonical reads. Similarly any read 
whose 5’ end was found anywhere between the start of the exon and 10 bp upstream of 
that 25 % max point was considered non-canonical. 
 
k-mer analysis 
Lists of all 6-mers and 3-mers present in reads mapping to exonic regions (as described 
above) were produced for each RIPiT-Seq sample. The ratio of total 3-mer frequency in 
RIPiT-Seq samples to RNA-Seq samples was then used to identify 3-mers enriched in 
alternate EJCs. 
 
Motif enrichment analysis  
Motif enrichment analysis was performed by first selecting RNA binding proteins of 
interest - namely SR proteins - from the position weight matrices (PWMs) available on 
http://rbpdb.ccbr.utoronto.ca/. For all reads mapped to exonic regions, a score was then 
generated representing the highest possible binding probability for each protein on that 
read. For visualization the cumulative distribution of these score frequencies was plotted 
for both pull down and RNA-Seq replicates, with a relatively higher score frequency at a 
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positive score implying greater binding affinity. The p-values between RIPiT-Seq and 
RNA-Seq replicates were also computed for every score using a negative binomial 
based model, with significant values primarily in positive score regions implying a 
binding preference for that protein. 
 
Differential enrichment analysis 
Differential analysis of exons and transcripts between CASC3 and RNPS1 pull down 
was conducted with the DESeq2 (Love et al., 2014) package in R. Exons and 
transcripts with significant differential expression (p < 0.05) were selected. All the 
following analysis was conducted using only the lists of significantly differentially 
expressed transcripts, unless otherwise noted. 
 
Estimation of nuclear versus cytoplasmic levels 
Nuclear and cytoplasmic RNA levels were estimated by first obtaining nuclear and 
cytoplasmic reads from (Neve et al., 2016). Reads were aligned and mapped to our 
exonic annotation as described above, and a ratio of nuclear to cytoplasmic reads was 
then calculated for all transcripts. 
 
Comparison to genes with detained introns 
A list of detained and non-detained introns was obtained from (Boutz et al., 2015). To 
identify detained intron containing and lacking genes in our RNA-Seq data, we carried 
out analysis using a DESeq2-based pipeline as described by Boutz et al. Briefly, using 
two RNA-Seq replicates we first created artificial data sets containing the same 
numbers of total reads per replicate, but with counts originating from introns in a given 
gene spread evenly amongst those introns in the artificial set. By comparing the intron 
distributions of these artificial replicates to the experimental replicates using DESeq we 
were able to produce lists of detained introns (introns with significantly (p < 0.05) higher 
expression levels compared to the artificially spread data) and non-detained introns 
(introns with non-significant (p > 0.1) expression levels compared to the artificially 
spread data). The transcripts containing introns found to be detained/non-detained in 
both our analysis and the analysis done by Boutz et al. make up the stringent lists, 
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which were used for analysis in Figure 4D. Of the 693 canonical genes containing 
detained introns reported by Boutz et al. we found 555 in our own analysis (80 %) and 
of the 5294 canonical genes lacking detained introns we found 812 (15 %). 
 
Features compared between two alternate EJC sets 
mRNA half life data was taken from (Tani et al., 2012) with no further processing on our 
part. Translation efficiency data was similarly obtained from (Kiss et al., 2017). 
 
Gene ontology analysis 
DAVID gene ontology tool (Huang et al., 2009) was used to compare the set of genes 
(canonical Ensembl transcript IDs) predicted by DESeq2 analysis to be significantly 
enriched in CASC3 or RNPS1 EJCs against a background list containing only those 
human genes that were reliably detected by DESeq2 (all genes for which DESeq2 
calculated adjusted p-values). Only non-redundant categories with lowest p-value (with 
Benjamini-Hochberg correction) are reported.   
